Positive	O
and	O
negative	O
regulation	O
of	O
immunoglobulin	B-DNA
gene	I-DNA
expression	O
by	O
a	O
novel	O
B-cell-specific	B-DNA
enhancer	I-DNA
element	I-DNA
.	O

A	O
new	O
B-cell-specific	B-DNA
enhancer	I-DNA
element	I-DNA
has	O
been	O
identified	O
3	O
'	O
of	O
E4	B-DNA
and	I-DNA
the	I-DNA
octamerlike	I-DNA
motifs	I-DNA
in	O
the	O
human	B-DNA
immunoglobulin	I-DNA
heavy-chain	I-DNA
gene	I-DNA
enhancer	I-DNA
.	O

Tandem	O
copies	O
of	O
this	O
67-bp	B-DNA
MnlI-AluI	I-DNA
fragment	I-DNA
,	O
when	O
fused	O
to	O
the	O
chloramphenicol	B-DNA
acetyltransferase	I-DNA
gene	I-DNA
driven	O
by	O
the	O
conalbumin	B-DNA
promoter	I-DNA
,	O
stimulated	O
transcription	O
in	O
B	B-cell_type
cells	I-cell_type
but	O
not	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
or	O
HeLa	B-cell_line
cells	I-cell_line
.	O

Footprinting	O
analysis	O
revealed	O
that	O
the	O
identical	O
sequence	O
CCGAAACTGAAAAGG	O
,	O
designated	O
E6	B-DNA
,	O
was	O
protected	O
by	O
nuclear	O
extracts	O
from	O
B	B-cell_type
cells	I-cell_type
,	O
T	B-cell_type
cells	I-cell_type
,	O
or	O
HeLa	O
cells	O
.	O

Gel	O
mobility	O
shift	O
assays	O
using	O
a	O
synthetic	B-DNA
E6	I-DNA
motif	I-DNA
detected	O
a	O
B-cell-specific	B-protein
complex	I-protein
in	O
addition	O
to	O
a	O
ubiquitous	O
band	O
found	O
also	O
in	O
T	B-cell_type
cells	I-cell_type
and	O
HeLa	B-cell_line
cells	I-cell_line
.	O

In	O
agreement	O
with	O
the	O
results	O
of	O
gel	O
retardation	O
assays	O
,	O
tandem	O
copies	O
of	O
the	O
E6	B-DNA
motif	I-DNA
stimulated	O
transcription	O
in	O
ARH77	B-cell_line
and	O
Raji	B-cell_line
cells	I-cell_line
but	O
not	O
in	O
Jurkat	B-cell_line
or	O
HeLa	B-cell_line
cells	I-cell_line
.	O

Furthermore	O
,	O
a	O
mutant	B-DNA
E6	I-DNA
motif	I-DNA
lost	O
both	O
in	O
vitro	O
binding	O
activity	O
and	O
in	O
vivo	O
enhancer	O
activity	O
.	O

In	O
striking	O
contrast	O
to	O
the	O
mouse	B-DNA
Ig	I-DNA
heavy-chain	I-DNA
enhancer	I-DNA
,	O
in	O
which	O
the	O
octamer	B-DNA
motif	I-DNA
acts	O
as	O
a	O
B-cell-specific	B-DNA
enhancer	I-DNA
element	I-DNA
,	O
the	O
human	B-DNA
enhancer	I-DNA
contains	O
an	O
octamerlike	B-DNA
sequence	I-DNA
with	O
one	O
base	O
substitution	O
which	O
bound	O
octamer-binding	B-protein
proteins	I-protein
with	O
only	O
very	O
low	O
affinity	O
and	O
showed	O
no	O
enhancer	O
activity	O
of	O
its	O
own	O
.	O

Interestingly	O
,	O
the	O
MnlI-AluI	B-DNA
fragment	I-DNA
could	O
suppress	O
the	O
basal-level	O
activity	O
of	O
the	O
conalbumin	B-DNA
promoter	I-DNA
in	O
both	O
Jurkat	B-cell_line
and	O
HeLa	B-cell_line
cells	I-cell_line
.	O

Moreover	O
,	O
simian	O
virus	O
40	O
enhancer	O
activity	O
was	O
blocked	O
by	O
the	O
MnlI-AluI	B-DNA
fragment	I-DNA
in	O
HeLa	B-cell_line
cells	I-cell_line
but	O
not	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

Thus	O
,	O
the	O
novel	O
enhancer	O
element	O
identified	O
in	O
this	O
study	O
is	O
probably	O
a	O
target	O
site	O
for	O
both	O
positive	B-protein
and	I-protein
negative	I-protein
factors	I-protein
.	O

MoLECcULAR	NULL
aND	NULL
CELLULAR	NULL
BioLOGY	NULL
,	NULL
Jan.	NULL
1991	NULL
,	NULL
p.	NULL
75-83	NULL
0270-7306/91/010075-09	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1991	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

11	NULL
,	NULL
No	NULL
.	NULL

1	NULL
Positive	NULL
and	NULL
Negative	NULL
Regulation	NULL
of	NULL
Immunoglobulin	NULL
Gene	NULL
Expression	NULL
by	NULL
a	NULL
Novel	NULL
B-Cell-Specific	NULL
Enhancer	NULL
Element	NULL
JIYANG	NULL
WANG	NULL
,	NULL
MAKOTO	NULL
OKETANI	NULL
,	NULL
anp	NULL
TAKESHI	NULL
WATANABE*	NULL
Medical	NULL
Institute	NULL
of	NULL
Bioregulation	NULL
,	NULL
Kyushu	NULL
University	NULL
,	NULL
Maidashi	NULL
3-1-1	NULL
,	NULL
Higashi-ku	NULL
,	NULL
Fukuoka	NULL
812	NULL
,	NULL
Japan	NULL
Received	NULL
14	NULL
August	NULL
1990/Accepted	NULL
29	NULL
September	NULL
1990	NULL
A	NULL
new	NULL
B-cell-specific	NULL
enhancer	NULL
element	NULL
has	NULL
been	NULL
identified	NULL
3	NULL
'	NULL
of	NULL
E4	NULL
and	NULL
the	NULL
octamerlike	NULL
motifs	NULL
in	NULL
the	NULL
human	NULL
immunoglobulin	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
.	NULL

Tandem	NULL
copies	NULL
of	NULL
this	NULL
67-bp	NULL
Mn/I-Alul	NULL
fragment	NULL
,	NULL
when	NULL
fused	NULL
to	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
conalbumin	NULL
promoter	NULL
,	NULL
stimulated	NULL
transcription	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
HeLa	NULL
cells	NULL
.	NULL

Footprinting	NULL
analysis	NULL
revealed	NULL
that	NULL
the	NULL
identical	NULL
sequence	NULL
CCGAAACTGAAAAGG	NULL
,	NULL
designated	NULL
E6	NULL
,	NULL
was	NULL
protected	NULL
by	NULL
nuclear	NULL
extracts	NULL
from	NULL
B	NULL
cells	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
or	NULL
HeLa	NULL
cells	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
a	NULL
synthetic	NULL
E6	NULL
motif	NULL
detected	NULL
a	NULL
B-cell-specific	NULL
complex	NULL
in	NULL
addition	NULL
to	NULL
a	NULL
ubiquitous	NULL
band	NULL
found	NULL
also	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
results	NULL
of	NULL
gel	NULL
retardation	NULL
assays	NULL
,	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
E6	NULL
motif	NULL
stimulated	NULL
transcription	NULL
in	NULL
ARH77	NULL
and	NULL
Raji	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Jurkat	NULL
or	NULL
HeLa	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
mutant	NULL
E6	NULL
motif	NULL
lost	NULL
both	NULL
in	NULL
vitro	NULL
binding	NULL
activity	NULL
and	NULL
in	NULL
vivo	NULL
enhancer	NULL
activity	NULL
.	NULL

In	NULL
striking	NULL
contrast	NULL
to	NULL
the	NULL
mouse	NULL
Ig	NULL
heavy-chain	NULL
enhancer	NULL
,	NULL
in	NULL
which	NULL
the	NULL
octamer	NULL
motif	NULL
acts	NULL
as	NULL
a	NULL
B-cell-specific	NULL
enhancer	NULL
element	NULL
,	NULL
the	NULL
human	NULL
enhancer	NULL
contains	NULL
an	NULL
octamerlike	NULL
sequence	NULL
with	NULL
one	NULL
base	NULL
substitution	NULL
which	NULL
bound	NULL
octamer-binding	NULL
proteins	NULL
with	NULL
only	NULL
very	NULL
low	NULL
affinity	NULL
and	NULL
showed	NULL
no	NULL
enhancer	NULL
activity	NULL
of	NULL
its	NULL
own	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
Mnil-Alul	NULL
fragment	NULL
could	NULL
suppress	NULL
the	NULL
basal-level	NULL
activity	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
simian	NULL
virus	NULL
40	NULL
enhancer	NULL
activity	NULL
was	NULL
blocked	NULL
by	NULL
the	NULL
Ma/l-Alul	NULL
fragment	NULL
in	NULL
HeLa	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
novel	NULL
enhancer	NULL
element	NULL
identified	NULL
in	NULL
this	NULL
study	NULL
is	NULL
probably	NULL
a	NULL
target	NULL
site	NULL
for	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
factors	NULL
.	NULL

Transcription	NULL
of	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
genes	NULL
is	NULL
regulated	NULL
by	NULL
at	NULL
least	NULL
two	NULL
elements	NULL
:	NULL
promoters	NULL
5°	NULL
of	NULL
V	NULL
regions	NULL
and	NULL
an	NULL
enhancer	NULL
within	NULL
the	NULL
J	NULL
(	NULL
joining	NULL
)	NULL
-C	NULL
(	NULL
constant	NULL
)	NULL
intron	NULL
(	NULL
3	NULL
,	NULL
7	NULL
,	NULL
11	NULL
,	NULL
13	NULL
,	NULL
25	NULL
,	NULL
27	NULL
,	NULL
28	NULL
,	NULL
31	NULL
)	NULL
.	NULL

The	NULL
J-C	NULL
intron	NULL
enhancer	NULL
probably	NULL
not	NULL
only	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
transcription	NULL
of	NULL
rearranged	NULL
Ig	NULL
genes	NULL
but	NULL
also	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
Ig	NULL
gene	NULL
rearrangement	NULL
during	NULL
B-cell	NULL
differentiation	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
Ig	NULL
gene	NULL
enhancer	NULL
is	NULL
strictly	NULL
regulated	NULL
by	NULL
multiple	NULL
trans-acting	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
and	NULL
with	NULL
cis-acting	NULL
enhancer	NULL
elements	NULL
.	NULL

Thus	NULL
,	NULL
identification	NULL
and	NULL
characterization	NULL
of	NULL
such	NULL
factors	NULL
,	NULL
especially	NULL
B-cell-specific	NULL
ones	NULL
,	NULL
is	NULL
important	NULL
for	NULL
elucidating	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
B	NULL
cells	NULL
differentiate	NULL
from	NULL
bone	NULL
marrow	NULL
stem	NULL
cells	NULL
.	NULL

The	NULL
mouse	NULL
Ig	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
has	NULL
been	NULL
investigated	NULL
by	NULL
many	NULL
groups	NULL
.	NULL

Several	NULL
enhancer	NULL
motifs	NULL
such	NULL
as	NULL
El	NULL
to	NULL
E5	NULL
and	NULL
the	NULL
octamer	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
6	NULL
)	NULL
.	NULL

These	NULL
motifs	NULL
bind	NULL
trans-acting	NULL
factors	NULL
that	NULL
act	NULL
collectively	NULL
to	NULL
enhance	NULL
transcription	NULL
(	NULL
15	NULL
,	NULL
23	NULL
,	NULL
34	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Among	NULL
these	NULL
,	NULL
the	NULL
octamer	NULL
sequence	NULL
ATTTGCAT	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
B-cell-specific	NULL
motif	NULL
that	NULL
binds	NULL
both	NULL
ubiquitous	NULL
(	NULL
octl	NULL
)	NULL
and	NULL
B-cell-specific	NULL
(	NULL
oct2A	NULL
and	NULL
oct2B	NULL
)	NULL
factors	NULL
(	NULL
10	NULL
,	NULL
22	NULL
,	NULL
35	NULL
,	NULL
36	NULL
,	NULL
38	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
negative	NULL
transcriptional	NULL
control	NULL
has	NULL
also	NULL
been	NULL
suggested	NULL
by	NULL
several	NULL
groups	NULL
(	NULL
17	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Two	NULL
repressor	NULL
elements	NULL
,	NULL
one	NULL
located	NULL
5	NULL
'	NULL
of	NULL
the	NULL
E2	NULL
motif	NULL
and	NULL
the	NULL
other	NULL
found	NULL
3	NULL
'	NULL
of	NULL
the	NULL
E4	NULL
and	NULL
octamer	NULL
motifs	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
by	NULL
deletion	NULL
analysis	NULL
(	NULL
2	NULL
,	NULL
16	NULL
,	NULL
18	NULL
,	NULL
32	NULL
,	NULL
33	NULL
,	NULL
41	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
regulation	NULL
seem	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
B-cell	NULL
specificity	NULL
of	NULL
the	NULL
whole	NULL
Ig	NULL
enhancer	NULL
.	NULL

The	NULL
human	NULL
Ig	NULL
heavy-chain	NULL
enhancer	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
same	NULL
complete	NULL
octamer	NULL
sequence	NULL
as	NULL
found	NULL
in	NULL
the	NULL
mouse	NULL
enhancer	NULL
.	NULL

Instead	NULL
,	NULL
it	NULL
contains	NULL
three	NULL
octamerlike	NULL
sequences	NULL
,	NULL
ATTTGCGT	NULL
,	NULL
ATGCAAAA	NULL
,	NULL
and	NULL
ATTTICAT	NULL
,	NULL
each	NULL
with	NULL
one	NULL
base	NULL
substitution	NULL
(	NULL
24	NULL
)	NULL
.	NULL

It	NULL
is	NULL
necessary	NULL
to	NULL
clarify	NULL
whether	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

75	NULL
these	NULL
octamerlike	NULL
sequences	NULL
act	NULL
as	NULL
B-cell-specific	NULL
enhancer	NULL
elements	NULL
and	NULL
bind	NULL
octamer-binding	NULL
proteins	NULL
.	NULL

Our	NULL
initial	NULL
studies	NULL
revealed	NULL
that	NULL
these	NULL
octamerlike	NULL
motifs	NULL
have	NULL
only	NULL
very	NULL
low	NULL
affinity	NULL
for	NULL
the	NULL
octamer-binding	NULL
proteins	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
binding	NULL
assay	NULL
,	NULL
indicating	NULL
that	NULL
there	NULL
could	NULL
be	NULL
other	NULL
B-cell-specific	NULL
elements	NULL
instead	NULL
of	NULL
these	NULL
octamerlike	NULL
sequences	NULL
.	NULL

With	NULL
the	NULL
aim	NULL
of	NULL
identifying	NULL
such	NULL
B-cell-specific	NULL
elements	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
human	NULL
Ig	NULL
gene	NULL
enhancer	NULL
in	NULL
detail	NULL
in	NULL
a	NULL
transient	NULL
in	NULL
vivo	NULL
assay	NULL
system	NULL
.	NULL

Short	NULL
segments	NULL
of	NULL
the	NULL
enhancer	NULL
and	NULL
polymers	NULL
of	NULL
them	NULL
were	NULL
tested	NULL
for	NULL
enhancer	NULL
activity	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
new	NULL
B-cell-specific	NULL
enhancer	NULL
element	NULL
located	NULL
3	NULL
'	NULL
of	NULL
the	NULL
E4	NULL
and	NULL
the	NULL
octamerlike	NULL
sequence	NULL
region	NULL
.	NULL

This	NULL
element	NULL
contains	NULL
a	NULL
novel	NULL
motif	NULL
named	NULL
E6	NULL
,	NULL
which	NULL
acts	NULL
as	NULL
an	NULL
enhancer	NULL
element	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Surprisingly	NULL
,	NULL
this	NULL
element	NULL
could	NULL
also	NULL
reduce	NULL
the	NULL
basal-level	NULL
activity	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
and	NULL
even	NULL
block	NULL
simian	NULL
virus	NULL
(	NULL
SV40	NULL
)	NULL
enhancer	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
element	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
Ig	NULL
gene	NULL
expression	NULL
.	NULL

Our	NULL
data	NULL
also	NULL
revealed	NULL
that	NULL
the	NULL
octamerlike	NULL
sequence	NULL
by	NULL
itself	NULL
showed	NULL
no	NULL
enhancer	NULL
activity	NULL
when	NULL
polymerized	NULL
but	NULL
could	NULL
increase	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
novel	NULL
B-cell-specific	NULL
element	NULL
identified	NULL
in	NULL
this	NULL
study	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Construction	NULL
of	NULL
plasmids	NULL
.	NULL

The	NULL
human	NULL
Ig	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
(	NULL
958-bp	NULL
Miul-Hpal	NULL
fragment	NULL
)	NULL
was	NULL
divided	NULL
into	NULL
six	NULL
fragments	NULL
.	NULL

Various	NULL
enhancer	NULL
deletion	NULL
mutants	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
either	NULL
5	NULL
'	NULL
upstream	NULL
or	NULL
3	NULL
'	NULL
downstream	NULL
of	NULL
plasmid	NULL
pconaCAT	NULL
(	NULL
20	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
conalbumin	NULL
promoter	NULL
driving	NULL
the	NULL
CAT	NULL
(	NULL
chloramphenicol	NULL
acetyltransfer-ase	NULL
)	NULL
gene	NULL
,	NULL
or	NULL
into	NULL
the	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
region	NULL
of	NULL
pIgCAT	NULL
(	NULL
containing	NULL
the	NULL
human	NULL
Ig	NULL
promoter	NULL
)	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
two	NULL
separate	NULL
fragments	NULL
were	NULL
ligated	NULL
to	NULL
obtain	NULL
an	NULL
internal	NULL
deletion	NULL
mutant	NULL
or	NULL
to	NULL
make	NULL
appropriate	NULL
combinations	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
76	NULL
WANG	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

ws	NULL
*	NULL
@	NULL
swaskip	NULL
0	NULL
es-	NULL
%	NULL
va-ce-	NULL
%	NULL
ca	NULL
--	NULL
«	NULL
4Bp	NULL
®	NULL
ca-	NULL
m=cdip	NULL
%	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

CAT	NULL
activities	NULL
of	NULL
various	NULL
enhancer	NULL
deletion	NULL
mutants	NULL
in	NULL
ARH77	NULL
,	NULL
a	NULL
human	NULL
plasmacytoma	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
human	NULL
Ig	NULL
heavy-chain	NULL
enhancer	NULL
was	NULL
divided	NULL
into	NULL
six	NULL
fragments	NULL
:	NULL
0	NULL
,	NULL
340	NULL
bp	NULL
;	NULL
1	NULL
,	NULL
176	NULL
bp	NULL
;	NULL
2	NULL
,	NULL
95	NULL
bp	NULL
;	NULL
3	NULL
,	NULL
123	NULL
bp	NULL
;	NULL
4	NULL
,	NULL
133	NULL
bp	NULL
;	NULL
and	NULL
5	NULL
,	NULL
96	NULL
bp	NULL
.	NULL

E1	NULL
,	NULL
E2	NULL
,	NULL
HE2	NULL
,	NULL
and	NULL
E4	NULL
motifs	NULL
were	NULL
determined	NULL
both	NULL
by	NULL
sequence	NULL
homology	NULL
to	NULL
the	NULL
mouse	NULL
enhancer	NULL
and	NULL
by	NULL
protein	NULL
binding	NULL
except	NULL
for	NULL
E4	NULL
,	NULL
which	NULL
has	NULL
not	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
a	NULL
factor	NULL
in	NULL
vitro	NULL
.	NULL

Three	NULL
octamerlike	NULL
sequences	NULL
(	NULL
each	NULL
with	NULL
one	NULL
base	NULL
change	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
oct	NULL
'	NULL
3	NULL
,	NULL
oct	NULL
'	NULL
4	NULL
,	NULL
and	NULL
oct	NULL
'	NULL
5	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
Ig	NULL
enhancer	NULL
(	NULL
lines	NULL
c	NULL
to	NULL
g	NULL
)	NULL
were	NULL
cloned	NULL
5	NULL
'	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
in	NULL
the	NULL
natural	NULL
orientation	NULL
and	NULL
transfected	NULL
into	NULL
ARH77	NULL
cells	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
.	NULL

Relative	NULL
CAT	NULL
activity	NULL
was	NULL
calculated	NULL
by	NULL
comparison	NULL
with	NULL
the	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
human	NULL
Ig	NULL
enhancer	NULL
,	NULL
whose	NULL
activity	NULL
was	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

Each	NULL
transfection	NULL
was	NULL
repeated	NULL
four	NULL
times	NULL
,	NULL
and	NULL
representative	NULL
data	NULL
are	NULL
shown	NULL
.	NULL

Means	NULL
+	NULL
standard	NULL
deviations	NULL
were	NULL
calculated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

purified	NULL
by	NULL
two	NULL
rounds	NULL
of	NULL
CsCl	NULL
gradient	NULL
ultracentrifugation	NULL
,	NULL
followed	NULL
by	NULL
dialysis	NULL
against	NULL
a	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
Tris	NULL
hydrochloride	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
.	NULL

Transfection	NULL
and	NULL
CAT	NULL
assay	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
protocol	NULL
as	NULL
described	NULL
by	NULL
Grosschedl	NULL
and	NULL
Baltimore	NULL
(	NULL
13	NULL
)	NULL
.	NULL

A	NULL
10-	NULL
to	NULL
15-pg	NULL
sample	NULL
of	NULL
plasmid	NULL
was	NULL
used	NULL
in	NULL
each	NULL
transfection	NULL
.	NULL

At	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
by	NULL
freezing	NULL
and	NULL
thawing	NULL
cells	NULL
suspended	NULL
in	NULL
a	NULL
lysate	NULL
buffer	NULL
(	NULL
250	NULL
mM	NULL
Tris	NULL
hydrochloride	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
,	NULL
5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
five	NULL
times	NULL
.	NULL

The	NULL
cell	NULL
lysates	NULL
were	NULL
centrifuged	NULL
for	NULL
10	NULL
min	NULL
at	NULL
15,000	NULL
rpm	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
used	NULL
in	NULL
the	NULL
CAT	NULL
assay	NULL
as	NULL
described	NULL
by	NULL
Gorman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
12	NULL
)	NULL
.	NULL

Representative	NULL
results	NULL
are	NULL
shown	NULL
.	NULL

Average	NULL
activity	NULL
+	NULL
standard	NULL
deviation	NULL
was	NULL
determined	NULL
by	NULL
densi-tometric	NULL
scanning	NULL
of	NULL
the	NULL
autoradiograms	NULL
from	NULL
two	NULL
to	NULL
four	NULL
independent	NULL
transfections	NULL
.	NULL

The	NULL
number	NULL
of	NULL
transfections	NULL
is	NULL
indicated	NULL
for	NULL
the	NULL
figures	NULL
and	NULL
tables	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
containing	NULL
12	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N'-2-ethane-sulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
;	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
4	NULL
mM	NULL
MgCi	NULL
;	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
12	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
pepstatin	NULL
A	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
U	NULL
of	NULL
aprotinin	NULL
INN	NULL
per	NULL
ml	NULL
,	NULL
appropriate	NULL
amounts	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
end-labeled	NULL
target	NULL
DNA	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
to	NULL
20	NULL
min	NULL
.	NULL

The	NULL
resulting	NULL
complex	NULL
was	NULL
loaded	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
acrylamide/bisacrylamide	NULL
weight	NULL
ratio	NULL
of	NULL
29:1	NULL
)	NULL
containing	NULL
6.7	NULL
mM	NULL
Tris	NULL
hydrochioride	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
3.3	NULL
mM	NULL
sodium	NULL
acetate	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
which	NULL
had	NULL
been	NULL
prerun	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
run	NULL
2	NULL
to	NULL
3	NULL
h	NULL
at	NULL
4°C	NULL
at	NULL
11	NULL
V/cm	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
autoradiographed	NULL
at	NULL
-80°C	NULL
with	NULL
intensifying	NULL
screens	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
assay	NULL
(	NULL
footprinting	NULL
)	NULL
.	NULL

Probes	NULL
for	NULL
footprinting	NULL
were	NULL
labeled	NULL
at	NULL
either	NULL
5	NULL
'	NULL
end	NULL
,	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

The	NULL
labeled	NULL
probes	NULL
were	NULL
gel	NULL
purified	NULL
,	NULL
extracted	NULL
with	NULL
phenol-chloroform-isoamyl	NULL
alcohol	NULL
(	NULL
25:24:1	NULL
)	NULL
,	NULL
and	NULL
precipitated	NULL
with	NULL
ethanol	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
contained	NULL
10°	NULL
cpm	NULL
of	NULL
labeled	NULL
probe	NULL
,	NULL
3	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
appropriate	NULL
amounts	NULL
of	NULL
nuclear	NULL
proteins	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
40	NULL
wl	NULL
in	NULL
the	NULL
buffer	NULL
used	NULL
in	NULL
the	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
mixtures	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
to	NULL
20	NULL
min	NULL
and	NULL
then	NULL
digested	NULL
with	NULL
DNase	NULL
I	NULL
(	NULL
0.25	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
60	NULL
s	NULL
at	NULL
20°C	NULL
.	NULL

Digestion	NULL
was	NULL
stopped	NULL
with	NULL
20	NULL
mM	NULL
EDTA	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
-0.2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-0.3	NULL
M	NULL
NaCl-2	NULL
pug	NULL
of	NULL
yeast	NULL
tRNA	NULL
per	NULL
ml	NULL
,	NULL
extracted	NULL
with	NULL
phenol	NULL
,	NULL
and	NULL
precipitated	NULL
with	NULL
ethanol	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
loaded	NULL
on	NULL
an	NULL
8	NULL
%	NULL
urea	NULL
gel	NULL
.	NULL

G+	NULL
A	NULL
cleavage	NULL
was	NULL
done	NULL
as	NULL
described	NULL
by	NULL
Maxam	NULL
and	NULL
Gilbert	NULL
(	NULL
26	NULL
)	NULL
.	NULL

RESULTS	NULL
Multiple	NULL
domains	NULL
are	NULL
required	NULL
for	NULL
strong	NULL
enhancer	NULL
activity	NULL
.	NULL

Deletion	NULL
mutants	NULL
of	NULL
the	NULL
human	NULL
Ig	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
were	NULL
cloned	NULL
5	NULL
'	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
conalbumin	NULL
promoter	NULL
,	NULL
and	NULL
transient	NULL
CAT	NULL
activity	NULL
was	NULL
examined	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
mouse	NULL
enhancer	NULL
,	NULL
the	NULL
human	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
contains	NULL
multiple	NULL
domains	NULL
.	NULL

Fragment	NULL
3	NULL
seemed	NULL
to	NULL
be	NULL
one	NULL
of	NULL
the	NULL
crucial	NULL
elements	NULL
,	NULL
since	NULL
any	NULL
combination	NULL
that	NULL
included	NULL
fragment	NULL
3	NULL
and	NULL
others	NULL
generally	NULL
exhibited	NULL
strong	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lines	NULL
f	NULL
and	NULL
g	NULL
)	NULL
.	NULL

Fragment	NULL
Ol	NULL
(	NULL
line	NULL
d	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
El	NULL
and	NULL
E2	NULL
motifs	NULL
,	NULL
had	NULL
little	NULL
Vor	NULL
.	NULL

11	NULL
,	NULL
1991	NULL
enhancer	NULL
activity	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
motifs	NULL
alone	NULL
are	NULL
not	NULL
sufficient	NULL
for	NULL
enhancer	NULL
activity	NULL
.	NULL

Fragment	NULL
012	NULL
(	NULL
line	NULL
e	NULL
)	NULL
had	NULL
only	NULL
moderate	NULL
enhancer	NULL
activity	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
observations	NULL
that	NULL
the	NULL
corresponding	NULL
region	NULL
in	NULL
the	NULL
mouse	NULL
enhancer	NULL
showed	NULL
strong	NULL
activity	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

This	NULL
difference	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
in	NULL
the	NULL
human	NULL
heavy-chain	NULL
enhancer	NULL
of	NULL
both	NULL
the	NULL
E3	NULL
motif	NULL
and	NULL
two	NULL
of	NULL
the	NULL
three	NULL
virus	NULL
enhancer	NULL
core	NULL
sequences	NULL
found	NULL
in	NULL
the	NULL
mouse	NULL
enhancer	NULL
.	NULL

The	NULL
E3	NULL
motif	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
strong	NULL
enhancer	NULL
element	NULL
(	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
instead	NULL
of	NULL
the	NULL
E3	NULL
motif	NULL
,	NULL
the	NULL
human	NULL
enhancer	NULL
contains	NULL
the	NULL
HE2	NULL
region	NULL
,	NULL
which	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
be	NULL
an	NULL
enhancer	NULL
motif	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Fragment	NULL
345	NULL
(	NULL
line	NULL
f	NULL
)	NULL
had	NULL
about	NULL
90	NULL
%	NULL
wild-type	NULL
enhancer	NULL
activity	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
only	NULL
10	NULL
to	NULL
30	NULL
%	NULL
activity	NULL
for	NULL
the	NULL
corresponding	NULL
region	NULL
in	NULL
the	NULL
mouse	NULL
enhancer	NULL
(	NULL
19	NULL
,	NULL
23	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Although	NULL
human	NULL
and	NULL
mouse	NULL
enhancers	NULL
are	NULL
active	NULL
in	NULL
cells	NULL
of	NULL
either	NULL
species	NULL
in	NULL
a	NULL
B-cell-specific	NULL
manner	NULL
,	NULL
some	NULL
motifs	NULL
(	NULL
such	NULL
as	NULL
El	NULL
,	NULL
E2	NULL
,	NULL
and	NULL
E4	NULL
)	NULL
are	NULL
found	NULL
in	NULL
both	NULL
enhancers	NULL
,	NULL
while	NULL
others	NULL
(	NULL
such	NULL
as	NULL
E3	NULL
and	NULL
the	NULL
octamer	NULL
)	NULL
are	NULL
not	NULL
found	NULL
in	NULL
the	NULL
human	NULL
enhancer	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
not	NULL
surprising	NULL
that	NULL
there	NULL
is	NULL
some	NULL
discrepancy	NULL
between	NULL
our	NULL
results	NULL
for	NULL
the	NULL
human	NULL
enhancer	NULL
and	NULL
other	NULL
reports	NULL
on	NULL
the	NULL
mouse	NULL
enhancer	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
these	NULL
enhancer	NULL
deletion	NULL
mutants	NULL
were	NULL
inserted	NULL
3	NULL
'	NULL
downstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
or	NULL
when	NULL
the	NULL
conalbumin	NULL
promoter	NULL
was	NULL
replaced	NULL
by	NULL
a	NULL
human	NULL
Ig	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
these	NULL
mutant	NULL
enhancers	NULL
into	NULL
NS1	NULL
,	NULL
a	NULL
mouse	NULL
myeloma	NULL
cell	NULL
line	NULL
,	NULL
revealed	NULL
similar	NULL
results	NULL
(	NULL
our	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Fragments	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
,	NULL
each	NULL
containing	NULL
an	NULL
octamerlike	NULL
sequence	NULL
,	NULL
exhibit	NULL
different	NULL
enhancer	NULL
activities	NULL
,	NULL
We	NULL
then	NULL
focused	NULL
on	NULL
fragment	NULL
345	NULL
,	NULL
not	NULL
only	NULL
because	NULL
it	NULL
showed	NULL
stronger	NULL
enhancer	NULL
activity	NULL
than	NULL
did	NULL
the	NULL
corresponding	NULL
region	NULL
of	NULL
mouse	NULL
enhancer	NULL
but	NULL
also	NULL
because	NULL
we	NULL
were	NULL
interested	NULL
in	NULL
examining	NULL
the	NULL
influence	NULL
of	NULL
the	NULL
three	NULL
octamerlike	NULL
sequences	NULL
contained	NULL
within	NULL
this	NULL
region	NULL
.	NULL

Fragment	NULL
3	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
line	NULL
j	NULL
)	NULL
but	NULL
not	NULL
fragments	NULL
4	NULL
and	NULL
5	NULL
(	NULL
lines	NULL
k	NULL
and	NULL
1	NULL
)	NULL
exhibited	NULL
enhancer	NULL
activity	NULL
.	NULL

Two	NULL
copies	NULL
of	NULL
fragment	NULL
3	NULL
were	NULL
as	NULL
active	NULL
as	NULL
the	NULL
wild-type	NULL
human	NULL
enhancer	NULL
(	NULL
line	NULL
a	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
two	NULL
copies	NULL
of	NULL
either	NULL
fragment	NULL
4	NULL
(	NULL
fragment	NULL
44	NULL
;	NULL
line	NULL
e	NULL
)	NULL
or	NULL
fragment	NULL
5	NULL
(	NULL
fragment	NULL
55	NULL
;	NULL
line	NULL
i	NULL
)	NULL
showed	NULL
no	NULL
enhancer	NULL
activity	NULL
.	NULL

Various	NULL
combinations	NULL
of	NULL
these	NULL
fragments	NULL
also	NULL
confirmed	NULL
that	NULL
only	NULL
fragment	NULL
3	NULL
stimulated	NULL
transcription	NULL
.	NULL

Combinations	NULL
of	NULL
fragments	NULL
4	NULL
and	NULL
5	NULL
(	NULL
fragments	NULL
45	NULL
and	NULL
54	NULL
;	NULL
lines	NULL
f	NULL
and	NULL
h	NULL
)	NULL
displayed	NULL
no	NULL
enhancer	NULL
activity	NULL
.	NULL

Only	NULL
the	NULL
combinations	NULL
that	NULL
contained	NULL
fragment	NULL
3	NULL
(	NULL
fragments	NULL
34	NULL
,	NULL
35	NULL
,	NULL
43	NULL
,	NULL
and	NULL
53	NULL
;	NULL
lines	NULL
b	NULL
,	NULL
c	NULL
,	NULL
d	NULL
,	NULL
and	NULL
g	NULL
)	NULL
were	NULL
active	NULL
.	NULL

Furthermore	NULL
,	NULL
combinations	NULL
in	NULL
which	NULL
fragment	NULL
3	NULL
was	NULL
placed	NULL
near	NULL
the	NULL
conalbumin	NULL
promoter	NULL
(	NULL
fragments	NULL
43	NULL
and	NULL
53	NULL
;	NULL
lines	NULL
d	NULL
and	NULL
g	NULL
)	NULL
exhibited	NULL
stronger	NULL
activity	NULL
than	NULL
did	NULL
the	NULL
reverse	NULL
combinations	NULL
(	NULL
fragments	NULL
34	NULL
and	NULL
35	NULL
;	NULL
lines	NULL
b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrated	NULL
that	NULL
fragment	NULL
3	NULL
,	NULL
but	NULL
not	NULL
fragment	NULL
4	NULL
or	NULL
5	NULL
,	NULL
exhibited	NULL
enhancer	NULL
activity	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
they	NULL
all	NULL
contain	NULL
an	NULL
octamerlike	NULL
sequence	NULL
.	NULL

Two	NULL
copies	NULL
of	NULL
fragment	NULL
3	NULL
,	NULL
when	NULL
cloned	NULL
3	NULL
'	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
,	NULL
also	NULL
strongly	NULL
stimulated	NULL
transcription	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
fragment	NULL
3	NULL
contains	NULL
an	NULL
enhancer	NULL
element	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
fragment	NULL
3	NULL
is	NULL
B-cell	NULL
specific	NULL
,	NULL
but	NULL
the	NULL
E4	NULL
and	NULL
oct	NULL
'	NULL
3	NULL
motifs	NULL
within	NULL
fragment	NULL
3	NULL
show	NULL
no	NULL
enhancer	NULL
activity	NULL
.	NULL

We	NULL
then	NULL
tested	NULL
the	NULL
cell	NULL
type	NULL
specificity	NULL
of	NULL
fragment	NULL
3	NULL
,	NULL
using	NULL
pSV2CAT	NULL
(	NULL
containing	NULL
the	NULL
SV40	NULL
promoter	NULL
and	NULL
enhancer	NULL
)	NULL
or	NULL
pSconaCAT	NULL
(	NULL
containing	NULL
the	NULL
conalbumin	NULL
promoter	NULL
and	NULL
SV40	NULL
enhancer	NULL
)	NULL
as	NULL
positive	NULL
controls	NULL
.	NULL

Fragment	NULL
3	NULL
or	NULL
its	NULL
dimers	NULL
exhibited	NULL
strong	NULL
enhancer	NULL
activity	NULL
in	NULL
ARH77	NULL
plasmacytoma	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
but	NULL
not	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3¢	NULL
)	NULL
.	NULL

The	NULL
Ddel-Hinfl	NULL
fragment	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
E4	NULL
and	NULL
octamer	NULL
motifs	NULL
in	NULL
the	NULL
mouse	NULL
enhancer	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
potent	NULL
B-cell-specific	NULL
enhancer	NULL
when	NULL
oligomerized	NULL
(	NULL
10	NULL
)	NULL
.	NULL

NOVEL	NULL
B-CELL-SPECIFIC	NULL
ENHANCER	NULL
ELEMENT	NULL
77	NULL
Enhancer	NULL
Relative	NULL
fragment	NULL
activity	NULL
(	NULL
%	NULL
of	NULL
wt	NULL
)	NULL
a	NULL
33	NULL
100+17	NULL
~	NULL
#	NULL
'	NULL
a	NULL
.	NULL

2:8	NULL
-	NULL
s	NULL
€	NULL
35	NULL
37+11	NULL
~	NULL
PR	NULL
d	NULL
43	NULL
71:23	NULL
&	NULL
€	NULL
44	NULL
6+3	NULL
m	NULL
45	NULL
§5+3	NULL
a	NULL
8	NULL
53	NULL
19+9	NULL
_	NULL
amp	NULL
#	NULL
h	NULL
54	NULL
4+2	NULL
Q	NULL
.	NULL

“	NULL
1	NULL
55	NULL
3+1	NULL
o	NULL
>	NULL
~-I	NULL
3	NULL
28+7	NULL
o-	NULL
-	NULL
<	NULL
%	NULL
k	NULL
4	NULL
4+2	NULL
o-	NULL
~R	NULL
1	NULL
§	NULL
2+1	NULL
o	NULL
--	NULL
~~	NULL
<	NULL
K©	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

CAT	NULL
activities	NULL
of	NULL
fragments	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
in	NULL
ARH77	NULL
cells	NULL
.	NULL

Fragment	NULL
3	NULL
,	NULL
4	NULL
,	NULL
or	NULL
5	NULL
cloned	NULL
into	NULL
the	NULL
Hincll	NULL
site	NULL
of	NULL
the	NULL
pUC	NULL
polylinker	NULL
was	NULL
cut	NULL
out	NULL
by	NULL
SphI	NULL
and	NULL
BamHI	NULL
digestion	NULL
and	NULL
recloned	NULL
into	NULL
the	NULL
Sphl	NULL
and	NULL
BamHI	NULL
site	NULL
5°	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
of	NULL
plasmid	NULL
pconaCAT	NULL
(	NULL
lines	NULL
j	NULL
to	NULL
1	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

7	NULL
for	NULL
the	NULL
restriction	NULL
enzyme	NULL
map	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
plasmids	NULL
were	NULL
then	NULL
digested	NULL
with	NULL
BamHI	NULL
,	NULL
and	NULL
fragment	NULL
3	NULL
,	NULL
4	NULL
,	NULL
or	NULL
5	NULL
was	NULL
again	NULL
cloned	NULL
into	NULL
this	NULL
BamHI	NULL
site	NULL
to	NULL
generate	NULL
nine	NULL
different	NULL
constructs	NULL
(	NULL
lines	NULL
a	NULL
to	NULL
i	NULL
)	NULL
.	NULL

Average	NULL
relative	NULL
CAT	NULL
activities	NULL
+	NULL
standard	NULL
deviations	NULL
were	NULL
calculated	NULL
from	NULL
four	NULL
independent	NULL
transfections	NULL
.	NULL

Fragment	NULL
3	NULL
contains	NULL
E4	NULL
and	NULL
an	NULL
octamerlike	NULL
(	NULL
oct	NULL
'	NULL
3	NULL
)	NULL
motif	NULL
,	NULL
the	NULL
sequences	NULL
of	NULL
which	NULL
are	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
corresponding	NULL
regions	NULL
of	NULL
the	NULL
mouse	NULL
enhancer	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
B-cell-specific	NULL
activity	NULL
of	NULL
fragment	NULL
3	NULL
is	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
E4	NULL
and	NULL
oct	NULL
'	NULL
3	NULL
motifs	NULL
,	NULL
fragment	NULL
3	NULL
was	NULL
further	NULL
divided	NULL
into	NULL
short	NULL
segments	NULL
by	NULL
digestion	NULL
with	NULL
restriction	NULL
enzymes	NULL
Ddel	NULL
and	NULL
Mill	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
two	NULL
synthetic	NULL
oligonucleotides	NULL
(	NULL
S43	NULL
and	NULL
$	NULL
35	NULL
)	NULL
were	NULL
made	NULL
to	NULL
cover	NULL
the	NULL
breakpoints	NULL
of	NULL
the	NULL
two	NULL
restriction	NULL
enzymes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
short	NULL
segments	NULL
and	NULL
polymers	NULL
of	NULL
two	NULL
to	NULL
six	NULL
copies	NULL
were	NULL
tested	NULL
for	NULL
enhancer	NULL
activity	NULL
.	NULL

In	NULL
striking	NULL
contrast	NULL
to	NULL
the	NULL
mouse	NULL
enhancer	NULL
,	NULL
up	NULL
to	NULL
six	NULL
copies	NULL
of	NULL
the	NULL
Bg/lI-Mnll	NULL
fragment	NULL
,	NULL
which	NULL
contains	NULL
both	NULL
the	NULL
E4	NULL
and	NULL
oct	NULL
'	NULL
3	NULL
motifs	NULL
,	NULL
showed	NULL
no	NULL
enhancer	NULL
activity	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
line	NULL
d	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
constructs	NULL
containing	NULL
up	NULL
to	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
$	NULL
43	NULL
oligonucleotide	NULL
,	NULL
which	NULL
also	NULL
contains	NULL
the	NULL
E4	NULL
and	NULL
oct	NULL
'	NULL
3	NULL
motifs	NULL
,	NULL
were	NULL
similarly	NULL
inactive	NULL
.	NULL

$	NULL
43	NULL
is	NULL
a	NULL
region	NULL
in	NULL
the	NULL
human	NULL
enhancer	NULL
corresponding	NULL
to	NULL
the	NULL
Ddel-Hinfl	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
enhancer	NULL
described	NULL
by	NULL
Gerster	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
,	NULL
the	NULL
restriction	NULL
sites	NULL
being	NULL
replaced	NULL
by	NULL
BamHI	NULL
sites	NULL
in	NULL
our	NULL
study	NULL
.	NULL

Gerster	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
strong	NULL
B-cell-specific	NULL
enhancer	NULL
activity	NULL
by	NULL
three	NULL
or	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
Ddel-Hinfl	NULL
fragment	NULL
and	NULL
showed	NULL
that	NULL
the	NULL
E4	NULL
and	NULL
octamer	NULL
motifs	NULL
were	NULL
responsible	NULL
for	NULL
this	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
our	NULL
data	NULL
suggests	NULL
that	NULL
the	NULL
human	NULL
E4	NULL
and	NULL
oct	NULL
'	NULL
3	NULL
region	NULL
can	NULL
not	NULL
stimulate	NULL
transcription	NULL
,	NULL
probably	NULL
because	NULL
of	NULL
its	NULL
limited	NULL
ability	NULL
to	NULL
bind	NULL
octamer-binding	NULL
proteins	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
six	NULL
copies	NULL
of	NULL
the	NULL
three	NULL
octamerlike	NULL
sequences	NULL
(	NULL
lines	NULL
h	NULL
,	NULL
i	NULL
,	NULL
and	NULL
j	NULL
)	NULL
showed	NULL
no	NULL
enhancer	NULL
activity	NULL
.	NULL

These	NULL
octamerlike	NULL
sequences	NULL
alone	NULL
may	NULL
be	NULL
too	NULL
weak	NULL
to	NULL
stimulate	NULL
transcription	NULL
,	NULL
suggesting	NULL
the	NULL
existence	NULL
of	NULL
other	NULL
B-cell-specific	NULL
enhancer	NULL
elements	NULL
.	NULL

78	NULL
WANG	NULL
ET	NULL
AL	NULL
.	NULL

pSV2	NULL
0	NULL
~	NULL
&	NULL
.	NULL

pScona	NULL
85+25	NULL
~	NULL
$	NULL
is	NULL
e	NULL
frag	NULL
.	NULL

33	NULL
87+11	NULL
~	NULL
c	NULL
.	NULL

b	NULL
peeve	NULL
100	NULL
cap	NULL
%	NULL
urkat	NULL
frag.3	NULL
3+	NULL
~	NULL
c	NULL
pScona	NULL
112+34	NULL
n	NULL
#	NULL
cla	NULL
frag.3	NULL
5+3	NULL
~	NULL
frag	NULL
33	NULL
4+3	NULL
n	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Enhancer	NULL
activities	NULL
of	NULL
fragment	NULL
3	NULL
or	NULL
dimer	NULL
33	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
.	NULL

ARH77	NULL
B	NULL
cells	NULL
(	NULL
a	NULL
)	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
b	NULL
)	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
(	NULL
c	NULL
)	NULL
were	NULL
transfected	NULL
and	NULL
analyzed	NULL
for	NULL
CAT	NULL
activity	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1.	NULL
pSV2CAT	NULL
(	NULL
containing	NULL
the	NULL
SV40	NULL
enhancer	NULL
and	NULL
promoter	NULL
)	NULL
and	NULL
pSconaCAT	NULL
(	NULL
containing	NULL
the	NULL
SV40	NULL
enhancer	NULL
conalbumin	NULL
promoter	NULL
)	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
controls	NULL
.	NULL

frag.3	NULL
and	NULL
frag.33	NULL
indicate	NULL
fragment	NULL
3	NULL
and	NULL
its	NULL
two	NULL
copies	NULL
cloned	NULL
5	NULL
'	NULL
of	NULL
conalbumin	NULL
promoter	NULL
.	NULL

Averages	NULL
+	NULL
standard	NULL
deviations	NULL
obtained	NULL
from	NULL
three	NULL
separate	NULL
transfections	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
Mnill-Alul	NULL
fragment	NULL
is	NULL
a	NULL
novel	NULL
B-cell-specific	NULL
enhancer	NULL
element	NULL
.	NULL

Enhancer	NULL
activity	NULL
was	NULL
found	NULL
in	NULL
the	NULL
67-bp	NULL
Mn/l-Alul	NULL
fragment	NULL
when	NULL
the	NULL
fragment	NULL
was	NULL
duplicated	NULL
to	NULL
three	NULL
or	NULL
four	NULL
copies	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
line	NULL
e	NULL
)	NULL
.	NULL

The	NULL
enhancer	NULL
activity	NULL
of	NULL
three	NULL
copies	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

of	NULL
this	NULL
fragment	NULL
was	NULL
almost	NULL
as	NULL
active	NULL
as	NULL
the	NULL
wild-type	NULL
enhancer	NULL
activity	NULL
in	NULL
ARH77	NULL
cells	NULL
.	NULL

To	NULL
date	NULL
,	NULL
no	NULL
motif	NULL
has	NULL
been	NULL
reported	NULL
within	NULL
this	NULL
fragment	NULL
,	NULL
either	NULL
by	NULL
factor	NULL
binding	NULL
or	NULL
by	NULL
in	NULL
vivo	NULL
functional	NULL
analysis	NULL
.	NULL

Therefore	NULL
,	NULL
this	NULL
fragment	NULL
represents	NULL
a	NULL
new	NULL
enhancer	NULL
element	NULL
in	NULL
the	NULL
human	NULL
Ig	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
.	NULL

Although	NULL
duplication	NULL
of	NULL
the	NULL
Bg/II-Ddel	NULL
fragment	NULL
exhibited	NULL
no	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
line	NULL
b	NULL
)	NULL
,	NULL
deletion	NULL
of	NULL
BgilI-Ddel	NULL
from	NULL
fragment	NULL
3	NULL
decreased	NULL
the	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
line	NULL
c	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
possible	NULL
enhancer	NULL
motifs	NULL
within	NULL
the	NULL
Bg/II-Ddel	NULL
fragment	NULL
.	NULL

Similarly	NULL
,	NULL
two	NULL
copies	NULL
of	NULL
Mnll-Alul	NULL
had	NULL
no	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
line	NULL
e	NULL
)	NULL
,	NULL
but	NULL
two	NULL
copies	NULL
of	NULL
Ddel-Alul	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
Ddel-Mnll	NULL
plus	NULL
Mnll-Alul	NULL
)	NULL
became	NULL
active	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
line	NULL
c	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
Ddel-Mnll	NULL
fragment	NULL
(	NULL
which	NULL
is	NULL
similar	NULL
to	NULL
oligonucleotide	NULL
$	NULL
43	NULL
except	NULL
for	NULL
lacking	NULL
6	NULL
bp	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
)	NULL
could	NULL
increase	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Mn/I-Alul	NULL
fragment	NULL
.	NULL

Unlike	NULL
the	NULL
mouse	NULL
E4	NULL
and	NULL
octamer	NULL
region	NULL
,	NULL
however	NULL
,	NULL
the	NULL
E4	NULL
and	NULL
oct	NULL
'	NULL
3	NULL
region	NULL
in	NULL
the	NULL
human	NULL
enhancer	NULL
could	NULL
not	NULL
act	NULL
as	NULL
an	NULL
enhancer	NULL
on	NULL
its	NULL
own	NULL
even	NULL
when	NULL
polymerized	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
B-cell-specific	NULL
enhancer	NULL
element	NULL
fragment	NULL
3	NULL
can	NULL
be	NULL
divided	NULL
into	NULL
three	NULL
elements	NULL
:	NULL
a	NULL
Mn/I-Alul	NULL
fragment	NULL
that	NULL
can	NULL
act	NULL
as	NULL
an	NULL
enhancer	NULL
when	NULL
oligomerized	NULL
and	NULL
two	NULL
other	NULL
fragments	NULL
(	NULL
BailI-Ddel	NULL
and	NULL
Ddel-Mnll	NULL
)	NULL
that	NULL
exhibit	NULL
enhancer	NULL
activity	NULL
only	NULL
when	NULL
combined	NULL
with	NULL
the	NULL
Mn/I-Alul	NULL
element	NULL
.	NULL

We	NULL
then	NULL
examined	NULL
whether	NULL
the	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
Mnll-Alul	NULL
fragment	NULL
is	NULL
B-cell	NULL
specific	NULL
.	NULL

Multiple	NULL
copies	NULL
of	NULL
this	NULL
fragment	NULL
stimulated	NULL
transcription	NULL
in	NULL
both	NULL
human	NULL
(	NULL
ARH77	NULL
)	NULL
and	NULL
mouse	NULL
(	NULL
X63	NULL
)	NULL
plasmacytoma	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Jurkat	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
oligomerized	NULL
Mn/l-Alul	NULL
fragment	NULL
reproducibly	NULL
decreased	NULL
basal-level	NULL
activity	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
;	NULL
compare	NULL
the	NULL
CAT	NULL
activity	NULL
of	NULL
pconaCAT	NULL
[	NULL
13	NULL
%	NULL
]	NULL
with	NULL
that	NULL
of	NULL
4x	NULL
Mnll-Alul	NULL
[	NULL
5	NULL
%	NULL
]	NULL
)	NULL
and	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
;	NULL
compare	NULL
the	NULL
activity	NULL
of	NULL
peonaCAT	NULL
[	NULL
12	NULL
%	NULL
]	NULL
with	NULL
that	NULL
of	NULL
4x	NULL
Mnll-Alul	NULL
[	NULL
1	NULL
%	NULL
]	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
suppressive	NULL
effect	NULL
of	NULL
this	NULL
element	NULL
in	NULL
non-B	NULL
cells	NULL
.	NULL

Relative	NULL
activity	NULL
(	NULL
%	NULL
of	NULL
wild	NULL
type	NULL
enhancer	NULL
)	NULL
Ix	NULL
2x	NULL
3x	NULL
4x	NULL
Sx	NULL
6x	NULL
(	NULL
copies	NULL
)	NULL
a	NULL
fragment	NULL
3	NULL
Bg=lll	NULL
D	NULL
:	NULL
del	NULL
35ja	NULL
“	NULL
Ni	NULL
!	NULL

!	NULL

!	NULL

“	NULL
Alf	NULL
]	NULL
28+7	NULL
100+17	NULL
b	NULL
BgliI-Ddel	NULL
<	NULL
1	NULL
<	NULL
1	NULL
<	NULL
1	NULL
c	NULL
Ddel-Alul	NULL
L	NULL
i	NULL
§+4	NULL
-	NULL
25+8	NULL
d	NULL
BglII	NULL
-Mall	NULL
<	NULL
1	NULL
<	NULL
1	NULL
<	NULL
1	NULL
<	NULL
1	NULL
<	NULL
1	NULL
<	NULL
1	NULL
e	NULL
Manll-Alul	NULL
f	NULL
--	NULL
-	NULL
3+2	NULL
<	NULL
l	NULL
-	NULL
83+22	NULL
164+47	NULL
f	NULL
$	NULL
35	NULL
i	NULL
--	NULL
--	NULL
--	NULL
A	NULL
<	NULL
1	NULL
8	NULL
S43	NULL
g	NULL
___	NULL
<	NULL
1	NULL
<	NULL
1	NULL
o	NULL
<	NULL
1	NULL
h	NULL
oct	NULL
'	NULL
3	NULL
(	NULL
ATITTGCGT	NULL
)	NULL
<	NULL
1	NULL
i	NULL
oct	NULL
'	NULL
4	NULL
(	NULL
ATGCAAAA	NULL
)	NULL
<	NULL
1	NULL
j	NULL
oct	NULL
'	NULL
5	NULL
(	NULL
ATTTTICAT	NULL
)	NULL
<	NULL
1	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

CAT	NULL
activities	NULL
of	NULL
short	NULL
segments	NULL
derived	NULL
from	NULL
fragment	NULL
3	NULL
,	NULL
the	NULL
two	NULL
synthetic	NULL
oligonucleotides	NULL
$	NULL
35	NULL
and	NULL
$	NULL
43	NULL
,	NULL
and	NULL
three	NULL
synthetic	NULL
octamerlike	NULL
sequences	NULL
.	NULL

Fragment	NULL
3	NULL
was	NULL
digested	NULL
with	NULL
Ddel	NULL
or	NULL
Mn/l	NULL
to	NULL
generate	NULL
four	NULL
different	NULL
segments	NULL
(	NULL
Bg/lI-Ddel	NULL
,	NULL
21	NULL
bp	NULL
;	NULL
Bgili-Mnil	NULL
,	NULL
60	NULL
bp	NULL
;	NULL
Mnll-Alul	NULL
,	NULL
67	NULL
bp	NULL
;	NULL
and	NULL
Ddel-Alul	NULL
,	NULL
100	NULL
bp	NULL
)	NULL
.	NULL

After	NULL
an	NULL
end-filling	NULL
reaction	NULL
with	NULL
bacteriophage	NULL
T4	NULL
DNA	NULL
polymerase	NULL
,	NULL
each	NULL
segment	NULL
was	NULL
ligated	NULL
with	NULL
T4	NULL
ligase	NULL
and	NULL
cloned	NULL
5°	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
.	NULL

$	NULL
35	NULL
contains	NULL
the	NULL
entire	NULL
sequence	NULL
of	NULL
the	NULL
Bg/lI-Ddel	NULL
fragment	NULL
plus	NULL
an	NULL
additional	NULL
8	NULL
bp	NULL
3	NULL
'	NULL
of	NULL
the	NULL
fragment	NULL
.	NULL

$	NULL
35	NULL
is	NULL
5-GATCCAGATCTGAAAGTGCTCTACTGAGCAAAACG-3	NULL
'	NULL
.	NULL

$	NULL
43	NULL
is	NULL
5-GATCCAACAACACCTGGACAATT	NULL
TGCGTTTCTAAAATAAGGCG-3	NULL
'	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
Ddel-Hinfl	NULL
fragment	NULL
that	NULL
contains	NULL
the	NULL
E4	NULL
and	NULL
octamer	NULL
motifs	NULL
in	NULL
the	NULL
mouse	NULL
enhancer	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
Ig	NULL
enhancer	NULL
was	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

Transfections	NULL
were	NULL
repeated	NULL
four	NULL
times	NULL
except	NULL
those	NULL
for	NULL
$	NULL
35	NULL
,	NULL
oct	NULL
'	NULL
3	NULL
,	NULL
oct	NULL
'	NULL
4	NULL
,	NULL
and	NULL
oct	NULL
'	NULL
5	NULL
,	NULL
which	NULL
were	NULL
repeated	NULL
only	NULL
twice	NULL
.	NULL

Means	NULL
+	NULL
standard	NULL
deviations	NULL
are	NULL
shown	NULL
.	NULL

Vor	NULL
.	NULL

11	NULL
,	NULL
1991	NULL
TABLE	NULL
1	NULL
.	NULL

Enhancer	NULL
activity	NULL
of	NULL
the	NULL
Mni/l-Alul	NULL
fragment	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
``	NULL
Activity	NULL
in	NULL
given	NULL
cell	NULL
type	NULL
(	NULL
avg	NULL
+	NULL
SD	NULL
)	NULL
Plasmid	NULL
ARH77	NULL
X63	NULL
Jurkat	NULL
HeLa	NULL
peonaCAT	NULL
al	NULL
7	NULL
+	NULL
3	NULL
11	NULL
+	NULL
2	NULL
9	NULL
+	NULL
3	NULL
3x	NULL
Mnll-Alul	NULL
49	NULL
+	NULL
16	NULL
ND	NULL
7	NULL
+	NULL
#	NULL
2	NULL
ND	NULL
4x	NULL
Mnll-Alul	NULL
93	NULL
+	NULL
27	NULL
69	NULL
+	NULL
11	NULL
3	NULL
+	NULL
1	NULL
<	NULL
1	NULL
``	NULL
The	NULL
Mnil-Alul	NULL
fragment	NULL
was	NULL
polymerized	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
plasmid	NULL
pconaCAT	NULL
.	NULL

*	NULL
Relative	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
pSconaCAT	NULL
,	NULL
which	NULL
was	NULL
set	NULL
at	NULL
100	NULL
;	NULL
calculated	NULL
from	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

ND	NULL
,	NULL
Not	NULL
determined	NULL
.	NULL

A	NULL
B-cell-specific	NULL
factor	NULL
binds	NULL
to	NULL
a	NULL
novel	NULL
enhancer	NULL
motif	NULL
E6	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
using	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
ARH77	NULL
or	NULL
Manca	NULL
cells	NULL
revealed	NULL
that	NULL
the	NULL
sequence	NULL
5-CCGAAACTGAAAAGG-3	NULL
'	NULL
(	NULL
designated	NULL
E6	NULL
)	NULL
was	NULL
protected	NULL
(	NULL
Fig	NULL
.	NULL

Sa	NULL
and	NULL
b	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
HeLa	NULL
cells	NULL
exhibited	NULL
a	NULL
protection	NULL
pattern	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
ARH77	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5c	NULL
)	NULL
.	NULL

We	NULL
then	NULL
tested	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
various	NULL
nuclear	NULL
extracts	NULL
in	NULL
a	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
,	NULL
using	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
comprising	NULL
the	NULL
E6	NULL
motif	NULL
.	NULL

All	NULL
of	NULL
the	NULL
tested	NULL
cell	NULL
lines	NULL
exhibited	NULL
a	NULL
common	NULL
retarded	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
closed	NULL
arrowheads	NULL
)	NULL
.	NULL

However	NULL
,	NULL
with	NULL
ARH77	NULL
plasmacytoma	NULL
cells	NULL
and	NULL
Manca	NULL
B	NULL
lym-phoblastoid	NULL
cells	NULL
,	NULL
another	NULL
retarded	NULL
species	NULL
that	NULL
migrated	NULL
faster	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

Ga	NULL
and	NULL
b	NULL
,	NULL
open	NULL
arrowheads	NULL
)	NULL
.	NULL

Both	NULL
complexes	NULL
could	NULL
be	NULL
abolished	NULL
by	NULL
the	NULL
synthetic	NULL
E6	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
a	NULL
mutant	NULL
one	NULL
.	NULL

Thus	NULL
,	NULL
two	NULL
kinds	NULL
of	NULL
factors	NULL
,	NULL
one	NULL
ubiquitous	NULL
and	NULL
the	NULL
other	NULL
B-cell	NULL
specific	NULL
,	NULL
bind	NULL
to	NULL
the	NULL
identical	NULL
DNA	NULL
motif	NULL
,	NULL
E6	NULL
.	NULL

The	NULL
sequence	NULL
CCGAAACTGAAAAGG	NULL
(	NULL
E6	NULL
)	NULL
acts	NULL
as	NULL
an	NULL
enhancer	NULL
element	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
E6	NULL
motif	NULL
,	NULL
which	NULL
was	NULL
protected	NULL
in	NULL
DNase	NULL
I	NULL
footprinting	NULL
assays	NULL
,	NULL
was	NULL
synthesized	NULL
and	NULL
polymerized	NULL
to	NULL
two	NULL
,	NULL
four	NULL
,	NULL
and	NULL
six	NULL
copies	NULL
.	NULL

Six	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
E6	NULL
motif	NULL
exhibited	NULL
enhancer	NULL
activity	NULL
in	NULL
ARH77	NULL
and	NULL
Raji	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Jurkat	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
a	NULL
mutant	NULL
E6	NULL
motif	NULL
,	NULL
which	NULL
had	NULL
lost	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
showed	NULL
no	NULL
enhancer	NULL
activity	NULL
.	NULL

\	NULL
NO	NULL
HB	NULL
WO	NULL
OBD	NULL
0	NULL
00	NULL
a+	NULL
gt	NULL
“	NULL
3	NULL
1	NULL
C	NULL
d	NULL
wo	NULL
mo	NULL
wew	NULL
amue	NULL
o	NULL
ao	NULL
A+G	NULL
man-unuuu-C	NULL
‘	NULL
WH	NULL
L	NULL
%	NULL
E6	NULL
#	NULL
#	NULL
B	NULL
A+G	NULL
811	NULL
%	NULL
:	NULL
#	NULL
90	NULL
»	NULL
*	NULL
E	NULL
M	NULL
is	NULL
:	NULL
:	NULL
T	NULL
NOVEL	NULL
B-CELL-SPECIFIC	NULL
ENHANCER	NULL
ELEMENT	NULL
79	NULL
Inhibition	NULL
of	NULL
SV40	NULL
enhancer	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
by	NULL
the	NULL
Mnll-Alul	NULL
fragment	NULL
.	NULL

The	NULL
novel	NULL
B-cell-specific	NULL
element	NULL
identified	NULL
in	NULL
this	NULL
study	NULL
is	NULL
located	NULL
22	NULL
bp	NULL
3	NULL
'	NULL
downstream	NULL
of	NULL
the	NULL
E4	NULL
and	NULL
oct	NULL
'	NULL
3	NULL
motifs	NULL
,	NULL
within	NULL
a	NULL
region	NULL
previously	NULL
found	NULL
to	NULL
contain	NULL
repressor	NULL
elements	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
three	NULL
or	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
Mnll-Alul	NULL
fragment	NULL
reduced	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
since	NULL
the	NULL
conalbumin	NULL
promoter	NULL
activity	NULL
itself	NULL
was	NULL
not	NULL
particularly	NULL
strong	NULL
,	NULL
it	NULL
was	NULL
difficult	NULL
to	NULL
conclusively	NULL
demonstrate	NULL
an	NULL
inhibitory	NULL
effect	NULL
in	NULL
non-B	NULL
cells	NULL
from	NULL
these	NULL
data	NULL
alone	NULL
.	NULL

Although	NULL
we	NULL
repeatedly	NULL
obtained	NULL
similar	NULL
inhibitory	NULL
results	NULL
,	NULL
to	NULL
confirm	NULL
that	NULL
there	NULL
was	NULL
a	NULL
suppressive	NULL
effect	NULL
in	NULL
non-B	NULL
cells	NULL
,	NULL
we	NULL
further	NULL
tested	NULL
the	NULL
Mnil-Alul	NULL
fragment	NULL
on	NULL
SV40	NULL
enhancer	NULL
activity	NULL
.	NULL

One	NULL
or	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
Mn/I-Alul	NULL
fragment	NULL
or	NULL
fragment	NULL
2	NULL
were	NULL
cloned	NULL
between	NULL
the	NULL
SV40	NULL
enhancer	NULL
and	NULL
the	NULL
conalbumin	NULL
promoter	NULL
driving	NULL
CAT	NULL
gene	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

We	NULL
placed	NULL
the	NULL
Mn/ll-Alul	NULL
fragment	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
because	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
efficient	NULL
inhibition	NULL
of	NULL
transcription	NULL
can	NULL
be	NULL
obtained	NULL
when	NULL
a	NULL
negative	NULL
control	NULL
element	NULL
is	NULL
located	NULL
close	NULL
to	NULL
the	NULL
promoter	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
SV40	NULL
enhancer	NULL
showed	NULL
strong	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
its	NULL
activity	NULL
was	NULL
repressed	NULL
by	NULL
the	NULL
Mnll-Alul	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lines	NULL
b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
enhancement	NULL
rather	NULL
than	NULL
suppression	NULL
was	NULL
observed	NULL
in	NULL
ARH77	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lines	NULL
b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

Suppression	NULL
of	NULL
SV40	NULL
enhancer	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
was	NULL
not	NULL
observed	NULL
when	NULL
fragment	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
line	NULL
d	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
virus	NULL
enhancer	NULL
core	NULL
sequence	NULL
,	NULL
was	NULL
inserted	NULL
between	NULL
the	NULL
SV	NULL
40	NULL
enhancer	NULL
and	NULL
the	NULL
conalbumin	NULL
promoter	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
the	NULL
Mrll-Alul	NULL
fragment	NULL
could	NULL
block	NULL
SV40	NULL
enhancer	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
ARH77	NULL
cells	NULL
further	NULL
suggests	NULL
that	NULL
different	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
E6	NULL
motif	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
Identification	NULL
of	NULL
a	NULL
novel	NULL
B-cell-specific	NULL
enhancer	NULL
element	NULL
.	NULL

Gerster	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
multiple	NULL
copies	NULL
of	NULL
a	NULL
Ddel-Hinfl	NULL
fragment	NULL
composed	NULL
of	NULL
the	NULL
E4	NULL
and	NULL
octamer	NULL
stimulate	NULL
transcription	NULL
only	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
human	NULL
Ig	NULL
enhancer	NULL
,	NULL
however	NULL
,	NULL
has	NULL
no	NULL
identical	NULL
octamer	NULL
sequence	NULL
but	NULL
instead	NULL
contains	NULL
three	NULL
octamerlike	NULL
sequences	NULL
,	NULL
each	NULL
with	NULL
one	NULL
&	NULL
BB	NULL
Hela	NULL
wi®o	NULL
#	NULL
#	NULL
#	NULL
Jurkat	NULL
E6	NULL
c	NULL
LL	NULL
L	NULL
de	NULL
dies	NULL
100g	NULL
¢	NULL
L	NULL
+	NULL
a	NULL
-	NULL
wasn	NULL
6	NULL
6	NULL
ihe	NULL
|	NULL
4	NULL
H4	NULL
€	NULL
8	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
assay	NULL
.	NULL

Fragment	NULL
3	NULL
was	NULL
end	NULL
labeled	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
with	NULL
[	NULL
y-P	NULL
]	NULL
ATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

The	NULL
footprinting	NULL
analysis	NULL
was	NULL
prepared	NULL
by	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
ARHT77	NULL
plasmacytoma	NULL
cells	NULL
(	NULL
a	NULL
)	NULL
,	NULL
Manca	NULL
B	NULL
cells	NULL
(	NULL
b	NULL
)	NULL
,	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
(	NULL
c	NULL
)	NULL
.	NULL

-	NULL
,	NULL
No	NULL
addition	NULL
of	NULL
extracts	NULL
.	NULL

80	NULL
WANG	NULL
ET	NULL
AL	NULL
.	NULL

Competitors	NULL
|	NULL
E6	NULL
el	NULL
uw	NULL
]	NULL
3	NULL
«	NULL
s	NULL
bf	NULL
a	NULL
p	NULL
muE6	NULL
°	NULL
E6	NULL
}	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

muE6	NULL
muE6	NULL
m	NULL
g	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Factors	NULL
binding	NULL
to	NULL
the	NULL
E6	NULL
motif	NULL
.	NULL

A	NULL
synthetic	NULL
E6	NULL
sequence	NULL
(	NULL
CCGAAACTGAAAAAG	NULL
)	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-PJATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
various	NULL
cell	NULL
lines	NULL
representing	NULL
plasma	NULL
cells	NULL
(	NULL
ARHT77	NULL
;	NULL
a	NULL
)	NULL
,	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
Manca	NULL
;	NULL
b	NULL
)	NULL
,	NULL
T	NULL
cells	NULL
(	NULL
Jurkat	NULL
;	NULL
c	NULL
)	NULL
,	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
(	NULL
HeLa	NULL
;	NULL
d	NULL
)	NULL
.	NULL

muE6	NULL
indicates	NULL
a	NULL
mutant	NULL
E6	NULL
sequence	NULL
(	NULL
CCtAAAC	NULL
TctAAAGG	NULL
)	NULL
.	NULL

base	NULL
variation	NULL
.	NULL

Our	NULL
results	NULL
showed	NULL
that	NULL
these	NULL
octamerlike	NULL
sequences	NULL
bind	NULL
an	NULL
octamer-binding	NULL
protein	NULL
(	NULL
oct1	NULL
,	NULL
oct2A	NULL
,	NULL
or	NULL
oct2B	NULL
)	NULL
only	NULL
with	NULL
very	NULL
low	NULL
affinity	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Fragment	NULL
3	NULL
,	NULL
which	NULL
contains	NULL
one	NULL
of	NULL
the	NULL
octamerlike	NULL
sequences	NULL
,	NULL
exhibited	NULL
enhancer	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
because	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
novel	NULL
B-cell-specific	NULL
element	NULL
identified	NULL
in	NULL
this	NULL
study	NULL
,	NULL
which	NULL
is	NULL
located	NULL
3	NULL
'	NULL
downstream	NULL
of	NULL
the	NULL
E4	NULL
and	NULL
oct	NULL
'	NULL
3	NULL
regions	NULL
.	NULL

To	NULL
date	NULL
,	NULL
most	NULL
studies	NULL
have	NULL
focused	NULL
on	NULL
the	NULL
El	NULL
to	NULL
E4	NULL
and	NULL
octamer	NULL
motifs	NULL
defined	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
by	NULL
Ephrussi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
6	NULL
)	NULL
.	NULL

This	NULL
novel	NULL
B-cell-specific	NULL
element	NULL
was	NULL
therefore	NULL
not	NULL
de-tected	NULL
.	NULL

Footprinting	NULL
analysis	NULL
revealed	NULL
protection	NULL
of	NULL
the	NULL
sequence	NULL
CCGAAACTGAAAAGG	NULL
(	NULL
E6	NULL
)	NULL
.	NULL

Multiple	NULL
copies	NULL
of	NULL
E6	NULL
alone	NULL
can	NULL
act	NULL
as	NULL
an	NULL
enhancer	NULL
in	NULL
ARH77	NULL
plasmacytoma	NULL
cells	NULL
or	NULL
Raji	NULL
B	NULL
ceils	NULL
but	NULL
not	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

A	NULL
computer	NULL
search	NULL
revealed	NULL
that	NULL
the	NULL
E6	NULL
motif	NULL
has	NULL
no	NULL
significant	NULL
homology	NULL
with	NULL
the	NULL
known	NULL
enhancer	NULL
motifs	NULL
.	NULL

Perfect	NULL
homology	NULL
to	NULL
the	NULL
sequence	NULL
AACTGAAA	NULL
within	NULL
the	NULL
E6	NULL
motif	NULL
,	NULL
however	NULL
,	NULL
was	NULL
found	NULL
in	NULL
the	NULL
regulatory	NULL
region	NULL
of	NULL
lymphotropic	NULL
papovavirus	NULL
(	NULL
29	NULL
)	NULL
and	NULL
in	NULL
the	NULL
5	NULL
'	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
interferon-B	NULL
gene	NULL
(	NULL
9	NULL
)	NULL
,	NULL
but	NULL
the	NULL
surrounding	NULL
sequences	NULL
are	NULL
different	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
six	NULL
copies	NULL
of	NULL
the	NULL
sequence	NULL
AACTGAAA	NULL
exhibited	NULL
no	NULL
enhancer	NULL
activity	NULL
in	NULL
ARH77	NULL
plasmacytoma	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
TABLE	NULL
2	NULL
.	NULL

B-cell-specific	NULL
activity	NULL
of	NULL
the	NULL
E6	NULL
motif	NULL
Activity	NULL
in	NULL
given	NULL
cell	NULL
type®	NULL
(	NULL
mean	NULL
+	NULL
SD	NULL
)	NULL
°	NULL
Plasmid	NULL
ARH77	NULL
Raji	NULL
Jurkat	NULL
HeLa	NULL
peonaCAT	NULL
<	NULL
1	NULL
2	NULL
+	NULL
2	NULL
11	NULL
+	NULL
2	NULL
9	NULL
+	NULL
3	NULL
2x	NULL
B6	NULL
<	NULL
1	NULL
ND	NULL
ND	NULL
ND	NULL
4xXE6	NULL
2	NULL
+	NULL
1	NULL
ND	NULL
ND	NULL
ND	NULL
6xE6	NULL
66	NULL
+	NULL
17	NULL
49	NULL
+	NULL
14	NULL
6	NULL
+	NULL
3	NULL
6	NULL
+	NULL
2	NULL
6xmuE6	NULL
5	NULL
+	NULL
3	NULL
3	NULL
+	NULL
2	NULL
7	NULL
+	NULL
2	NULL
7	NULL
*	NULL
3	NULL
``	NULL
The	NULL
wild-type	NULL
E6	NULL
sequence	NULL
(	NULL
E6	NULL
)	NULL
or	NULL
a	NULL
mutant	NULL
sequence	NULL
(	NULL
muE6	NULL
;	NULL
CCtAAAC	NULL
TctAAAGG	NULL
)	NULL
was	NULL
polymerized	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
plasmid	NULL
pconaCAT	NULL
.	NULL

®	NULL
Relative	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
pSconaCAT	NULL
,	NULL
which	NULL
was	NULL
set	NULL
at	NULL
100	NULL
;	NULL
determined	NULL
from	NULL
four	NULL
independent	NULL
transfections	NULL
.	NULL

ND	NULL
,	NULL
Not	NULL
determined	NULL
.	NULL

E6	NULL
motif	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
partial	NULL
repeats	NULL
:	NULL
CCGAAA	NULL
and	NULL
CTGAAA	NULL
.	NULL

The	NULL
E6-binding	NULL
proteins	NULL
may	NULL
recognize	NULL
these	NULL
related	NULL
short	NULL
sequences	NULL
with	NULL
different	NULL
affinities	NULL
.	NULL

Whereas	NULL
three	NULL
or	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
Mn/I-Alul	NULL
fragment	NULL
acted	NULL
as	NULL
an	NULL
enhancer	NULL
,	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
E6	NULL
motif	NULL
could	NULL
not	NULL
stimulate	NULL
transcription	NULL
.	NULL

Two	NULL
possible	NULL
explanations	NULL
for	NULL
this	NULL
result	NULL
can	NULL
be	NULL
considered	NULL
.	NULL

The	NULL
first	NULL
is	NULL
that	NULL
the	NULL
sequences	NULL
surrounding	NULL
the	NULL
E6	NULL
motif	NULL
are	NULL
also	NULL
important	NULL
for	NULL
the	NULL
activity	NULL
,	NULL
for	NULL
example	NULL
,	NULL
by	NULL
stabilizing	NULL
the	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
E6	NULL
motif	NULL
.	NULL

The	NULL
second	NULL
is	NULL
that	NULL
there	NULL
are	NULL
other	NULL
,	NULL
unidentified	NULL
motifs	NULL
within	NULL
the	NULL
Mnll-Alul	NULL
fragment	NULL
,	NULL
which	NULL
may	NULL
act	NULL
collectively	NULL
with	NULL
the	NULL
E6	NULL
SV40	NULL
enhancer	NULL
Kpni	NULL
_	NULL
72bp	NULL
72bpP	NULL
-	NULL
BamHI	NULL
“	NULL
W	NULL
BamHI	NULL
y-cona	NULL
*	NULL
--	NULL
--	NULL
-_	NULL
_	NULL
I	NULL
-289	NULL
*1	NULL
CAT	NULL
SphI	NULL
%	NULL
CAT	NULL
activity	NULL
ig	NULL
Enhancer	NULL
fragment	NULL
ARHT77	NULL
Hela	NULL
a.	NULL
no	NULL
fragment	NULL
100	NULL
100	NULL
b	NULL
.	NULL

1XMnil-Alul	NULL
115+33	NULL
9+5	NULL
c.	NULL
4XMnil-Alul	NULL
170+44	NULL
5+3	NULL
d.	NULL
fragment	NULL
2	NULL
118+31	NULL
93+26	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Suppression	NULL
of	NULL
SV40	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
Mn/l-Alul	NULL
fragment	NULL
.	NULL

One	NULL
or	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
Mnil-Alul	NULL
fragment	NULL
and	NULL
the	NULL
human	NULL
Ig	NULL
heavy-chain	NULL
enhancer	NULL
fragment	NULL
2	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
-102	NULL
BamHI	NULL
site	NULL
,	NULL
5	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
driving	NULL
CAT	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
SV40	NULL
enhancer	NULL
72-bp	NULL
repeat	NULL
was	NULL
then	NULL
cloned	NULL
into	NULL
the	NULL
-289	NULL
SphI	NULL
site	NULL
in	NULL
the	NULL
indicated	NULL
orientation	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
plasmid	NULL
containing	NULL
only	NULL
the	NULL
SV40	NULL
enhancer	NULL
was	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

Averages	NULL
+	NULL
standard	NULL
deviations	NULL
are	NULL
derived	NULL
from	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

Vor	NULL
.	NULL

11	NULL
,	NULL
1991	NULL
motif	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
clarify	NULL
this	NULL
phenome-non	NULL
.	NULL

As	NULL
revealed	NULL
by	NULL
gel	NULL
retardation	NULL
assays	NULL
,	NULL
a	NULL
ubiquitous	NULL
factor	NULL
bound	NULL
to	NULL
the	NULL
E6	NULL
motif	NULL
was	NULL
found	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
all	NULL
cell	NULL
lines	NULL
.	NULL

An	NULL
additional	NULL
factor	NULL
faster	NULL
in	NULL
mobility	NULL
than	NULL
the	NULL
ubiquitous	NULL
factor	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

At	NULL
present	NULL
,	NULL
we	NULL
can	NULL
only	NULL
speculate	NULL
that	NULL
this	NULL
species	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
B-cell	NULL
specificity	NULL
of	NULL
the	NULL
Mn/l-Alul	NULL
fragment	NULL
and	NULL
the	NULL
E6	NULL
motif	NULL
.	NULL

Despite	NULL
the	NULL
different	NULL
mobilities	NULL
of	NULL
the	NULL
two	NULL
species	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
,	NULL
the	NULL
two	NULL
E6-binding	NULL
proteins	NULL
protected	NULL
identical	NULL
sequences	NULL
in	NULL
footprinting	NULL
assays	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
probably	NULL
recognized	NULL
the	NULL
same	NULL
motif	NULL
.	NULL

They	NULL
are	NULL
similar	NULL
in	NULL
this	NULL
regard	NULL
to	NULL
octl	NULL
,	NULL
oct2B	NULL
,	NULL
and	NULL
oct2A	NULL
(	NULL
10	NULL
,	NULL
22	NULL
,	NULL
35	NULL
,	NULL
36	NULL
,	NULL
38	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
functional	NULL
assays	NULL
revealed	NULL
that	NULL
the	NULL
E6	NULL
motif	NULL
is	NULL
active	NULL
only	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
two	NULL
factors	NULL
likely	NULL
have	NULL
different	NULL
activities	NULL
.	NULL

Compared	NULL
with	NULL
octamer-binding	NULL
proteins	NULL
,	NULL
the	NULL
E6-binding	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
present	NULL
at	NULL
lower	NULL
levels	NULL
.	NULL

Preliminary	NULL
results	NULL
using	NULL
nuclear	NULL
proteins	NULL
size	NULL
fractionated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
elec-trophoresis	NULL
(	NULL
14	NULL
)	NULL
indicate	NULL
that	NULL
the	NULL
B-cell-specific	NULL
E6-binding	NULL
protein	NULL
has	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
between	NULL
45	NULL
and	NULL
67-kDa	NULL
{	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
SV40	NULL
enhancer	NULL
by	NULL
the	NULL
Mn/l-Alul	NULL
fragment	NULL
in	NULL
Hela	NULL
cells	NULL
.	NULL

An	NULL
interesting	NULL
phenomenon	NULL
observed	NULL
in	NULL
this	NULL
study	NULL
was	NULL
that	NULL
the	NULL
Mn/l-Alul	NULL
fragment	NULL
suppressed	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

This	NULL
inhibition	NULL
was	NULL
not	NULL
so	NULL
dramatic	NULL
,	NULL
probably	NULL
because	NULL
the	NULL
basal-level	NULL
activity	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
itself	NULL
was	NULL
relatively	NULL
low	NULL
.	NULL

When	NULL
the	NULL
SV40	NULL
enhancer	NULL
was	NULL
inserted	NULL
5	NULL
'	NULL
of	NULL
the	NULL
Mnill-Alul	NULL
fragment	NULL
,	NULL
the	NULL
inhibition	NULL
was	NULL
clearly	NULL
evident	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
no	NULL
inhibition	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
activity	NULL
was	NULL
rather	NULL
elevated	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
Mn/l-Alul	NULL
fragment	NULL
not	NULL
only	NULL
is	NULL
a	NULL
B-cell-specific	NULL
enhancer	NULL
element	NULL
but	NULL
also	NULL
likely	NULL
participates	NULL
in	NULL
the	NULL
inactivation	NULL
of	NULL
the	NULL
Ig	NULL
gene	NULL
enhancer	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

Previous	NULL
studies	NULL
revealed	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
Ig	NULL
genes	NULL
is	NULL
both	NULL
positively	NULL
and	NULL
negatively	NULL
regulated	NULL
.	NULL

By	NULL
introducing	NULL
deleted	NULL
or	NULL
mutated	NULL
enhancers	NULL
into	NULL
T	NULL
cells	NULL
or	NULL
nonlymphoid	NULL
cells	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
Ig	NULL
gene	NULL
enhancer	NULL
contains	NULL
a	NULL
ubiquitous	NULL
enhancer	NULL
in	NULL
the	NULL
central	NULL
region	NULL
including	NULL
E2	NULL
,	NULL
E3	NULL
,	NULL
and	NULL
core	NULL
sequences	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Sequences	NULL
5	NULL
'	NULL
upstream	NULL
of	NULL
the	NULL
ubiquitous	NULL
enhancer	NULL
and	NULL
3	NULL
'	NULL
downstream	NULL
of	NULL
the	NULL
E4	NULL
and	NULL
octamer	NULL
region	NULL
have	NULL
been	NULL
defined	NULL
as	NULL
negative	NULL
control	NULL
elements	NULL
,	NULL
since	NULL
deletion	NULL
of	NULL
each	NULL
region	NULL
led	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
Ig	NULL
gene	NULL
enhancer	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
16	NULL
,	NULL
18	NULL
,	NULL
32	NULL
,	NULL
33	NULL
,	NULL
41	NULL
,	NULL
43	NULL
)	NULL
.	NULL

The	NULL
newly	NULL
identified	NULL
B-cell-specific	NULL
element	NULL
is	NULL
located	NULL
22	NULL
bp	NULL
3	NULL
'	NULL
downstream	NULL
of	NULL
the	NULL
E4	NULL
and	NULL
oct	NULL
'	NULL
3	NULL
motifs	NULL
.	NULL

This	NULL
region	NULL
corresponds	NULL
to	NULL
a	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
enhancer	NULL
contained	NULL
within	NULL
the	NULL
negative	NULL
control	NULL
element	NULL
as	NULL
defined	NULL
by	NULL
Kadesch	NULL
et	NULL
al	NULL
.	NULL

(	NULL
18	NULL
)	NULL
.	NULL

They	NULL
were	NULL
,	NULL
however	NULL
,	NULL
unable	NULL
to	NULL
determine	NULL
the	NULL
short	NULL
segment	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
repression	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
,	NULL
the	NULL
Mn/l-Alul	NULL
fragment	NULL
blocked	NULL
SV40	NULL
enhancer	NULL
activity	NULL
in	NULL
our	NULL
assay	NULL
system	NULL
.	NULL

This	NULL
result	NULL
suggested	NULL
to	NULL
us	NULL
that	NULL
the	NULL
Mn/l-Alul	NULL
fragment	NULL
may	NULL
also	NULL
block	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
ubiquitous	NULL
enhancer	NULL
found	NULL
in	NULL
the	NULL
central	NULL
region	NULL
of	NULL
the	NULL
Ig	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
.	NULL

Enhancers	NULL
in	NULL
general	NULL
contain	NULL
multiple	NULL
elements	NULL
.	NULL

Likewise	NULL
,	NULL
multiple	NULL
repressor	NULL
elements	NULL
may	NULL
also	NULL
be	NULL
required	NULL
for	NULL
the	NULL
suppression	NULL
of	NULL
Ig	NULL
gene	NULL
expression	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

The	NULL
newly	NULL
identified	NULL
B-cell-specific	NULL
enhancer	NULL
element	NULL
Mn/I-Alul	NULL
may	NULL
be	NULL
one	NULL
of	NULL
such	NULL
repressor	NULL
elements	NULL
in	NULL
non-B	NULL
cells	NULL
.	NULL

The	NULL
mechanism	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
SV40	NULL
enhancer	NULL
activity	NULL
is	NULL
unknown	NULL
.	NULL

The	NULL
putative	NULL
inhibitory	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
E6	NULL
motif	NULL
are	NULL
likely	NULL
to	NULL
act	NULL
through	NULL
the	NULL
promoter	NULL
,	NULL
since	NULL
this	NULL
element	NULL
reduced	NULL
the	NULL
basal-level	NULL
activity	NULL
of	NULL
the	NULL
conalbumin	NULL
NOVEL	NULL
B-CELL-SPECIFIC	NULL
ENHANCER	NULL
ELEMENT	NULL
81	NULL
promoter	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

Even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
SV40	NULL
enhancer	NULL
,	NULL
the	NULL
Mnil-Alul	NULL
fragment	NULL
reduced	NULL
activity	NULL
to	NULL
a	NULL
level	NULL
lower	NULL
than	NULL
the	NULL
basal	NULL
activity	NULL
(	NULL
compare	NULL
Table	NULL
1	NULL
with	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
in	NULL
this	NULL
case	NULL
the	NULL
inhibition	NULL
effect	NULL
is	NULL
dominant	NULL
to	NULL
the	NULL
enhancer	NULL
and	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
close	NULL
proximity	NULL
of	NULL
the	NULL
Mn/l-Alul	NULL
fragment	NULL
to	NULL
the	NULL
conalbumin	NULL
promoter	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
SV40	NULL
enhancer	NULL
could	NULL
also	NULL
be	NULL
explained	NULL
by	NULL
interference	NULL
of	NULL
an	NULL
inactive	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
.	NULL

Suppression	NULL
of	NULL
SV40	NULL
enhancer	NULL
activity	NULL
was	NULL
not	NULL
observed	NULL
when	NULL
other	NULL
DNA	NULL
fragments	NULL
such	NULL
as	NULL
fragment	NULL
2	NULL
were	NULL
cloned	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
,	NULL
therefore	NULL
ruling	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
any	NULL
DNA	NULL
fragment	NULL
closely	NULL
located	NULL
5°	NULL
of	NULL
the	NULL
promoter	NULL
would	NULL
inhibit	NULL
its	NULL
activity	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
showed	NULL
that	NULL
different	NULL
factors	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
bind	NULL
to	NULL
the	NULL
E6	NULL
motif	NULL
.	NULL

However	NULL
,	NULL
footprinting	NULL
analysis	NULL
revealed	NULL
identical	NULL
protection	NULL
patterns	NULL
by	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
ARH77	NULL
plasmacytoma	NULL
cells	NULL
or	NULL
from	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
same	NULL
cis-acting	NULL
E6	NULL
motif	NULL
within	NULL
the	NULL
Mni/l-Alul	NULL
fragment	NULL
mediates	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
transcriptional	NULL
regulation	NULL
.	NULL

The	NULL
nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
same	NULL
E6	NULL
motif	NULL
may	NULL
exhibit	NULL
different	NULL
activities	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
non-B	NULL
cells	NULL
.	NULL

The	NULL
E4	NULL
and	NULL
oct	NULL
'	NULL
3	NULL
region	NULL
alone	NULL
can	NULL
not	NULL
act	NULL
as	NULL
an	NULL
enhancer	NULL
element	NULL
.	NULL

The	NULL
E4	NULL
and	NULL
oct	NULL
'	NULL
3	NULL
region	NULL
is	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
mouse	NULL
E4	NULL
and	NULL
octamer	NULL
region	NULL
and	NULL
was	NULL
expected	NULL
to	NULL
have	NULL
enhancer	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
our	NULL
data	NULL
clearly	NULL
demonstrated	NULL
that	NULL
this	NULL
region	NULL
has	NULL
no	NULL
enhancer	NULL
activity	NULL
by	NULL
itself	NULL
,	NULL
although	NULL
it	NULL
could	NULL
act	NULL
collectively	NULL
when	NULL
combined	NULL
with	NULL
the	NULL
Mn/l-A/lul	NULL
fragment	NULL
.	NULL

This	NULL
was	NULL
revealed	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
Ddel-Alul	NULL
fragment	NULL
had	NULL
activity	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
activity	NULL
of	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
Mnll-Alul	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lines	NULL
c	NULL
and	NULL
d	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
Bg/II-Ddel	NULL
fragment	NULL
exhibited	NULL
no	NULL
enhancer	NULL
activity	NULL
of	NULL
its	NULL
own	NULL
,	NULL
although	NULL
its	NULL
deletion	NULL
resulted	NULL
in	NULL
a	NULL
great	NULL
decrease	NULL
of	NULL
enhancer	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lines	NULL
b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
two	NULL
other	NULL
enhancer	NULL
elements	NULL
within	NULL
fragment	NULL
3	NULL
,	NULL
Bg/lI-Ddel	NULL
and	NULL
Ddel-Mnll	NULL
,	NULL
both	NULL
of	NULL
which	NULL
could	NULL
act	NULL
synergistically	NULL
with	NULL
the	NULL
B-cell-specific	NULL
enhancer	NULL
element	NULL
Mn/I-Alul	NULL
.	NULL

The	NULL
octamer	NULL
sequence	NULL
ATGCAAAT	NULL
or	NULL
its	NULL
inverse	NULL
complement	NULL
ATTTGCAT	NULL
is	NULL
found	NULL
in	NULL
the	NULL
promoters	NULL
as	NULL
well	NULL
as	NULL
the	NULL
enhancer	NULL
of	NULL
Ig	NULL
genes	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
lymphoid-specific	NULL
transcription	NULL
.	NULL

A	NULL
mutation	NULL
in	NULL
any	NULL
of	NULL
the	NULL
first	NULL
7	NULL
bp	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
ATGCAAAT	NULL
abolished	NULL
its	NULL
in	NULL
vivo	NULL
promoter	NULL
activity	NULL
as	NULL
well	NULL
as	NULL
its	NULL
in	NULL
vivo	NULL
binding	NULL
activity	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
oct	NULL
'	NULL
3	NULL
(	NULL
ATTTGCGT	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
oct	NULL
'	NULL
4	NULL
and	NULL
oct	NULL
'	NULL
5	NULL
,	NULL
bound	NULL
octamer-binding	NULL
proteins	NULL
with	NULL
only	NULL
very	NULL
low	NULL
affinity	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
,	NULL
correlating	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
enhancer	NULL
activity	NULL
of	NULL
this	NULL
sequence	NULL
.	NULL

Wirth	NULL
et	NULL
al	NULL
.	NULL

(	NULL
42	NULL
)	NULL
showed	NULL
that	NULL
a	NULL
mutant	NULL
octamer	NULL
sequence	NULL
ATGCAAAG	NULL
,	NULL
which	NULL
is	NULL
also	NULL
found	NULL
in	NULL
the	NULL
SV40	NULL
enhancer	NULL
,	NULL
retained	NULL
approximately	NULL
30	NULL
to	NULL
40	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
octamer	NULL
sequence	NULL
;	NULL
however	NULL
,	NULL
the	NULL
oct	NULL
'	NULL
4	NULL
with	NULL
a	NULL
mutation	NULL
at	NULL
the	NULL
same	NULL
location	NULL
(	NULL
ATGCAAAA	NULL
)	NULL
found	NULL
in	NULL
the	NULL
human	NULL
enhancer	NULL
seems	NULL
to	NULL
have	NULL
little	NULL
activity	NULL
,	NULL
since	NULL
neither	NULL
two	NULL
copies	NULL
of	NULL
fragment	NULL
4	NULL
(	NULL
which	NULL
contains	NULL
oct	NULL
'	NULL
4	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
line	NULL
e	NULL
)	NULL
nor	NULL
six	NULL
copies	NULL
of	NULL
oct	NULL
'	NULL
4	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
line	NULL
i	NULL
)	NULL
showed	NULL
activity	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
octamerlike	NULL
sequences	NULL
in	NULL
the	NULL
human	NULL
enhancer	NULL
,	NULL
however	NULL
,	NULL
was	NULL
compensated	NULL
for	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
E6	NULL
motif	NULL
identified	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
new	NULL
B-cell-specific	NULL
enhancer	NULL
was	NULL
identified	NULL
3	NULL
'	NULL
downstream	NULL
of	NULL
the	NULL
Ca	NULL
gene	NULL
(	NULL
30	NULL
)	NULL
.	NULL

As	NULL
suggested	NULL
by	NULL
the	NULL
authors	NULL
,	NULL
the	NULL
3	NULL
'	NULL
enhancer	NULL
may	NULL
be	NULL
activated	NULL
at	NULL
later	NULL
stages	NULL
of	NULL
B-cell	NULL
maturation	NULL
as	NULL
a	NULL
transcriptional	NULL
enhancer	NULL
.	NULL

The	NULL
J-C	NULL
intron	NULL
enhancer	NULL
becomes	NULL
active	NULL
during	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
,	NULL
and	NULL
its	NULL
activation	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
asso-	NULL
82	NULL
WANG	NULL
ET	NULL
AL	NULL
.	NULL

ciated	NULL
with	NULL
Ig	NULL
gene	NULL
rearrangement	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
novel	NULL
enhancer	NULL
element	NULL
identified	NULL
in	NULL
our	NULL
study	NULL
is	NULL
particularly	NULL
intriguing	NULL
since	NULL
it	NULL
likely	NULL
interacts	NULL
with	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
factors	NULL
.	NULL

Gene	NULL
cloning	NULL
of	NULL
trans-acting	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
this	NULL
element	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
better	NULL
understand	NULL
the	NULL
mechanism	NULL
of	NULL
the	NULL
activation	NULL
or	NULL
suppression	NULL
of	NULL
the	NULL
Ig	NULL
gene	NULL
enhancer	NULL
that	NULL
is	NULL
implicated	NULL
in	NULL
B-cell	NULL
differentiation	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
gratefully	NULL
acknowledge	NULL
P.	NULL
Burrows	NULL
and	NULL
C.	NULL
Cote	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
and	NULL
Culture	NULL
in	NULL
Japan	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Araki	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Maeda	NULL
,	NULL
J.	NULL
Wang	NULL
,	NULL
D.	NULL
Kitamura	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1988	NULL
.	NULL

Purification	NULL
of	NULL
a	NULL
nuclear	NULL
trans-acting	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
regulated	NULL
transcription	NULL
of	NULL
a	NULL
human	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
gene	NULL
.	NULL

Cell	NULL
53:723-730	NULL
.	NULL

2	NULL
.	NULL

Augereau	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
mouse	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
:	NULL
effect	NULL
on	NULL
transcription	NULL
in	NULL
vitro	NULL
and	NULL
binding	NULL
of	NULL
proteins	NULL
present	NULL
in	NULL
Hela	NULL
and	NULL
lymphoid	NULL
B	NULL
cell	NULL
extracts	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

5:1791-1797	NULL
.	NULL

3	NULL
.	NULL

Banerji	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Olson	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1983	NULL
.	NULL

A	NULL
lymphocyte-specific	NULL
cellular	NULL
enhancer	NULL
is	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
joining	NULL
region	NULL
in	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
genes	NULL
.	NULL

Cell	NULL
33:729-740	NULL
.	NULL

4	NULL
.	NULL

Cook	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Neuberger	NULL
.	NULL

1990	NULL
.	NULL

Lymphoid-specific	NULL
transcriptional	NULL
activation	NULL
by	NULL
components	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
:	NULL
studies	NULL
on	NULL
the	NULL
E2/E3	NULL
and	NULL
octa-nucleotide	NULL
elements	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:3565-3571	NULL
.	NULL

5	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebowitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

6	NULL
.	NULL

Ephrussi	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
M.	NULL
Church	NULL
,	NULL
S.	NULL
Tonegawa	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1985	NULL
.	NULL

B	NULL
lineage	NULL
specific	NULL
interactions	NULL
of	NULL
an	NULL
immunoglobulin	NULL
enhancer	NULL
with	NULL
cellular	NULL
factors	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
227:134-140	NULL
.	NULL

7	NULL
.	NULL

Falkner	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
and	NULL
H.	NULL
G.	NULL
Zachau	NULL
.	NULL

1984	NULL
.	NULL

Correct	NULL
transcription	NULL
of	NULL
an	NULL
immunoglobulin	NULL
«	NULL
gene	NULL
requires	NULL
an	NULL
upstream	NULL
fragment	NULL
containing	NULL
conserved	NULL
sequence	NULL
elements	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
310:71-74	NULL
.	NULL

8	NULL
.	NULL

Ferrier	NULL
,	NULL
P.	NULL
,	NULL
B.	NULL
Krippl	NULL
,	NULL
T.	NULL
K.	NULL
Blackwell	NULL
,	NULL
A.	NULL
J.	NULL
W.	NULL
Furley	NULL
,	NULL
H.	NULL
Suh	NULL
,	NULL
A.	NULL
Winoto	NULL
,	NULL
W.	NULL
D.	NULL
Cook	NULL
,	NULL
L.	NULL
Hood	NULL
,	NULL
F.	NULL
Costantini	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1990	NULL
.	NULL

Separate	NULL
elements	NULL
control	NULL
DJ	NULL
and	NULL
VDJ	NULL
rearrangement	NULL
in	NULL
a	NULL
transgenic	NULL
recombination	NULL
substrate	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:117-125	NULL
.	NULL

9	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Sakakibara	NULL
,	NULL
Y.	NULL
Sudo	NULL
,	NULL
M.	NULL
Miyamoto	NULL
,	NULL
Y.	NULL
Kimura	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1988	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
,	NULL
IRF-I	NULL
,	NULL
mediating	NULL
induction	NULL
and	NULL
silencing	NULL
properties	NULL
to	NULL
human	NULL
INF-B	NULL
gene	NULL
regulatory	NULL
elements	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:3397-3405	NULL
.	NULL

10	NULL
.	NULL

Gerster	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
Thali	NULL
,	NULL
J.	NULL
Jiricny	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1987	NULL
.	NULL

Cell	NULL
type	NULL
specificity	NULL
elements	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
gene	NULL
enhancer	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:1323-1330	NULL
.	NULL

11	NULL
.	NULL

Gillies	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
S.	NULL
L.	NULL
Morrison	NULL
,	NULL
V.	NULL
T.	NULL
Oi	NULL
,	NULL
and	NULL
S.	NULL
Tonegawa	NULL
.	NULL

1983	NULL
.	NULL

A	NULL
tissue-specific	NULL
transcription	NULL
enhancer	NULL
element	NULL
is	NULL
located	NULL
in	NULL
the	NULL
major	NULL
intron	NULL
of	NULL
a	NULL
rearranged	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
gene	NULL
.	NULL

Cell	NULL
33:717-728	NULL
.	NULL

12	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
L.	NULL
F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2:1044-1051	NULL
.	NULL

13	NULL
.	NULL

Grosschedl	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1985	NULL
.	NULL

Cell	NULL
type	NULL
specificity	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
at	NULL
least	NULL
three	NULL
DNA	NULL
elements	NULL
.	NULL

Cell	NULL
41:885-897	NULL
.	NULL

14	NULL
.	NULL

Hager	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
R.	NULL
R.	NULL
Burgess	NULL
.	NULL

1980	NULL
.	NULL

Elution	NULL
of	NULL
proteins	NULL
from	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gels	NULL
,	NULL
removal	NULL
of	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
and	NULL
renaturation	NULL
of	NULL
enzymatic	NULL
activity	NULL
:	NULL
results	NULL
with	NULL
sigma	NULL
subunit	NULL
of	NULL
Escherichia	NULL
coli	NULL
RNA	NULL
polymerase	NULL
,	NULL
wheat	NULL
germ	NULL
DNA	NULL
topoisomerase	NULL
,	NULL
and	NULL
other	NULL
enzymes	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

109:76-86	NULL
.	NULL

15	NULL
.	NULL

Henthorn	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Kiledjian	NULL
,	NULL
T.	NULL
Kadesch	NULL
.	NULL

1990	NULL
.	NULL

Two	NULL
distinct	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
wES/kE2	NULL
motif	NULL
.	NULL

Science	NULL
247:467-470	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Imler	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
C.	NULL
Lemaire	NULL
,	NULL
C.	NULL
Wasylyk	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1987	NULL
.	NULL

Negative	NULL
regulation	NULL
contributes	NULL
to	NULL
tissue	NULL
specificity	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:2558-2567	NULL
.	NULL

Ishihara	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Kudo	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1984	NULL
.	NULL

Induction	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
in	NULL
fibroblasts	NULL
by	NULL
cyclohexi-mide	NULL
treatment	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

160:1937-1942	NULL
.	NULL

Kadesch	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
Zervos	NULL
,	NULL
and	NULL
D.	NULL
Ruezinsky	NULL
.	NULL

1986	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
murine	NULL
IgH	NULL
enhancer	NULL
:	NULL
evidence	NULL
for	NULL
negative	NULL
control	NULL
of	NULL
cell-type	NULL
specificity	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:8209-8221	NULL
.	NULL

Kiledjian	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
K.	NULL
Su	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
two	NULL
functional	NULL
domains	NULL
within	NULL
the	NULL
murine	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:145-152	NULL
.	NULL

Kimura	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
B.	NULL
Odile	NULL
,	NULL
and	NULL
P.	NULL
Kourilsky	NULL
.	NULL

1986	NULL
.	NULL

Detailed	NULL
analysis	NULL
of	NULL
the	NULL
mouse	NULL
H-2K	NULL
``	NULL
promoter	NULL
:	NULL
enhancer-like	NULL
sequences	NULL
and	NULL
their	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
class	NULL
I	NULL
gene	NULL
expression	NULL
.	NULL

Cell	NULL
44:261-272	NULL
.	NULL

Kitamura	NULL
,	NULL
D.	NULL
,	NULL
H.	NULL
Maeda	NULL
,	NULL
K.	NULL
Araki	NULL
,	NULL
A.	NULL
Kudo	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
by	NULL
labile	NULL
repressor	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

17:1249-1256	NULL
.	NULL

Landolfi	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
J.	NULL
D.	NULL
Capra	NULL
,	NULL
and	NULL
P.W	NULL
.	NULL

Turker	NULL
.	NULL

1986	NULL
.	NULL

Interaction	NULL
of	NULL
cell	NULL
type	NULL
specific	NULL
nuclear	NULL
proteins	NULL
with	NULL
immunoglobulin	NULL
V	NULL
;	NULL
,	NULL
promoter	NULL
region	NULL
sequences	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
323:548-551	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
W.	NULL
Pierce	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

Protein-binding	NULL
sites	NULL
in	NULL
Ig	NULL
gene	NULL
enhancers	NULL
determine	NULL
transcriptional	NULL
activity	NULL
and	NULL
inducibility	NULL
.	NULL

Science	NULL
236:1573-1577	NULL
.	NULL

Maeda	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Araki	NULL
,	NULL
D.	NULL
Kitamura	NULL
,	NULL
J.	NULL
Wang	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1987	NULL
.	NULL

Nuclear	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
human	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:2851-2869	NULL
.	NULL

Mason	NULL
,	NULL
J.	NULL
O.	NULL
,	NULL
G.	NULL
T.	NULL
Williams	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Neuberger	NULL
.	NULL

1985	NULL
.	NULL

Transcription	NULL
cell	NULL
type	NULL
specificity	NULL
is	NULL
conferred	NULL
by	NULL
an	NULL
immunoglobulin	NULL
V	NULL
,	NULL
,	NULL
;	NULL
gene	NULL
promoter	NULL
that	NULL
includes	NULL
a	NULL
functional	NULL
consensus	NULL
sequence	NULL
.	NULL

Cell	NULL
41:479-487	NULL
.	NULL

Maxam	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1980	NULL
.	NULL

Sequencing	NULL
end-labeled	NULL
DNA	NULL
with	NULL
base-specific	NULL
chemical	NULL
cleavages	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

65:490-560	NULL
.	NULL

Neuberger	NULL
,	NULL
M.	NULL
S.	NULL
1983	NULL
.	NULL

Expression	NULL
and	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
gene	NULL
transfected	NULL
into	NULL
lymphoid	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

2:1373-1378	NULL
.	NULL

Parslow	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
D.	NULL
L.	NULL
Blair	NULL
,	NULL
W.	NULL
J.	NULL
Murphy	NULL
,	NULL
and	NULL
D.	NULL
K.	NULL
Granner	NULL
.	NULL

1984	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
5°	NULL
ends	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
:	NULL
a	NULL
novel	NULL
conserved	NULL
sequence	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:2650-2654	NULL
.	NULL

Pettersson	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
purine-rich	NULL
DNA	NULL
sequence	NULL
motif	NULL
present	NULL
in	NULL
SV40	NULL
and	NULL
lymphotropic	NULL
papovavirus	NULL
binds	NULL
a	NULL
lymphoid-specific	NULL
factor	NULL
and	NULL
contributes	NULL
to	NULL
enhance	NULL
activity	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1:962-972	NULL
.	NULL

Pettersson	NULL
,	NULL
S.	NULL
,	NULL
G.	NULL
P.	NULL
Cook	NULL
,	NULL
M.	NULL
Bruggemann	NULL
,	NULL
G.	NULL
T.	NULL
Williams	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Neuberger	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
second	NULL
B	NULL
cell-specific	NULL
enhancer	NULL
3	NULL
'	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
locus	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
:	NULL
165-168	NULL
.	NULL

Picard	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1985	NULL
.	NULL

Cell-type	NULL
preference	NULL
of	NULL
immunoglobulin	NULL
and	NULL
lambda	NULL
gene	NULL
promoters	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

4:2831-2838	NULL
.	NULL

Scheuermann	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
U.	NULL
Chen	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
developmental-specific	NULL
factor	NULL
binds	NULL
to	NULL
suppressor	NULL
sites	NULL
flanking	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
gene	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1255-1266	NULL
.	NULL

Scholer	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
and	NULL
P.	NULL
Gruss	NULL
.	NULL

1985	NULL
.	NULL

Cell	NULL
type-specific	NULL
transcriptional	NULL
enhancement	NULL
in	NULL
vitro	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
trans-acting	NULL
factors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

4:3005-3013	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
sequence	NULL
.	NULL

Cell	NULL
46	NULL
:	NULL
705-716	NULL
.	NULL

Singh	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
conserved	NULL
sequence	NULL
motif	NULL
in	NULL
transcriptional	NULL
control	NULL
elements	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
319:154-158	NULL
.	NULL

Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
H.	NULL
Singh	NULL
,	NULL
R.	NULL
Sen.	NULL
T.	NULL
Wirth	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
lymphoid-specific	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
motif	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
323	NULL
:	NULL
640-643	NULL
.	NULL

Tsao	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
X.	NULL
F.	NULL
Wang	NULL
,	NULL
C.	NULL
L.	NULL
Peterson	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1988	NULL
.	NULL

In	NULL
vivo	NULL
functional	NULL
analysis	NULL
of	NULL
in	NULL
vitro	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
Vor	NULL
.	NULL

11	NULL
,	NULL
1991	NULL
38	NULL
.	NULL

39.	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
enhancer	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16:3239-3253	NULL
.	NULL

Wang	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
Nishiyama	NULL
,	NULL
K.	NULL
Araki	NULL
,	NULL
D.	NULL
Kitamura	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1987	NULL
.	NULL

Purification	NULL
of	NULL
an	NULL
octamer	NULL
sequence	NULL
(	NULL
ATGCAAAT	NULL
)	NULL
-binding	NULL
protein	NULL
from	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
:	NULL
10105-10116	NULL
.	NULL

Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
immunoglobulin	NULL
heavy-chain	NULL
B-lymphocyte	NULL
enhancer	NULL
efficiently	NULL
stimulates	NULL
transcription	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

5:553-560.	NULL
.	NULL

Weinberger	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1986	NULL
.	NULL

Distinct	NULL
factors	NULL
bind	NULL
to	NULL
apparently	NULL
homologous	NULL
sequences	NULL
in	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

Nature	NULL
322:846-848	NULL
.	NULL

NOVEL	NULL
B-CELL-SPECIFIC	NULL
ENHANCER	NULL
ELEMENT	NULL
83	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

Weinberger	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
S.	NULL
Jat	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1988	NULL
.	NULL

Localization	NULL
of	NULL
a	NULL
repressive	NULL
sequence	NULL
contributing	NULL
to	NULL
B-cell	NULL
specificity	NULL
in	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:988-992	NULL
.	NULL

Wirth	NULL
,	NULL
T.	NULL
,	NULL
L.	NULL
Staudt	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
octamer	NULL
oligonucleotide	NULL
upstream	NULL
of	NULL
a	NULL
TATA	NULL
motif	NULL
is	NULL
sufficient	NULL
for	NULL
lymphoid-specific	NULL
promoter	NULL
activity	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
329:174-178	NULL
.	NULL

Zaller	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
H.	NULL
Yu	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Eckhardt	NULL
.	NULL

1988	NULL
.	NULL

Genes	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
immunoglobulin	NULL
enhancer	NULL
or	NULL
promoter	NULL
are	NULL
negatively	NULL
regulated	NULL
by	NULL
a	NULL
T-lymphoma	NULL
cell	NULL
line	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1932-1939	NULL
.	NULL

